Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-107 ACVR1 1.49 0.00013 -0.76 0.04389 miRanda -0.13 0.02288 NA
2 hsa-miR-142-3p ACVR1 4.35 0 -0.76 0.04389 miRanda -0.17 0 NA
3 hsa-miR-148b-3p ACVR1 1.76 0 -0.76 0.04389 MirTarget -0.32 0 NA
4 hsa-miR-16-2-3p ACVR1 3.8 0 -0.76 0.04389 mirMAP -0.12 0.00315 NA
5 hsa-miR-186-5p ACVR1 0.45 0.18545 -0.76 0.04389 miRNAWalker2 validate -0.3 0 NA
6 hsa-miR-197-3p ACVR1 1.24 0.00733 -0.76 0.04389 miRNAWalker2 validate -0.11 0.02374 NA
7 hsa-miR-19b-3p ACVR1 1.68 0.00086 -0.76 0.04389 miRNAWalker2 validate -0.16 0.00012 NA
8 hsa-miR-30b-5p ACVR1 0.02 0.95322 -0.76 0.04389 MirTarget -0.17 0.00144 NA
9 hsa-miR-30c-5p ACVR1 0.39 0.34861 -0.76 0.04389 MirTarget; miRNATAP -0.17 0.001 NA
10 hsa-miR-30d-5p ACVR1 0.3 0.38019 -0.76 0.04389 MirTarget; miRNATAP -0.14 0.03381 NA
11 hsa-miR-30e-5p ACVR1 0.78 0.03467 -0.76 0.04389 MirTarget -0.29 0 NA
12 hsa-miR-320a ACVR1 -0.91 0.05656 -0.76 0.04389 miRanda -0.13 0.00356 NA
13 hsa-miR-338-3p ACVR1 0.45 0.55849 -0.76 0.04389 MirTarget; PITA; miRanda; miRNATAP -0.11 5.0E-5 NA
14 hsa-miR-362-3p ACVR1 0.68 0.22615 -0.76 0.04389 miRanda -0.14 0.00018 NA
15 hsa-miR-454-3p ACVR1 1.4 0.00366 -0.76 0.04389 MirTarget; miRNATAP -0.12 0.00599 NA
16 hsa-miR-590-3p ACVR1 2.35 0 -0.76 0.04389 miRanda -0.21 0 NA
17 hsa-let-7d-5p ACVR1C 0.83 0.0127 1.69 0.1187 MirTarget; miRNATAP -0.37 0.04936 NA
18 hsa-let-7e-5p ACVR1C -0.11 0.81474 1.69 0.1187 MirTarget; miRNATAP -0.53 5.0E-5 NA
19 hsa-let-7g-5p ACVR1C 0.86 0.00648 1.69 0.1187 MirTarget; miRNATAP -0.48 0.01705 NA
20 hsa-miR-129-5p ACVR1C -2.67 0.00696 1.69 0.1187 miRanda -0.18 0.00498 NA
21 hsa-miR-130a-5p ACVR1C 1.58 0.02435 1.69 0.1187 miRNATAP -0.28 0.00144 NA
22 hsa-miR-181b-5p ACVR1C 1.11 0.02734 1.69 0.1187 miRNATAP -0.31 0.01166 NA
23 hsa-miR-181c-5p ACVR1C -0.3 0.53753 1.69 0.1187 miRNATAP -0.28 0.02714 NA
24 hsa-miR-26b-5p ACVR1C 0.31 0.46163 1.69 0.1187 MirTarget; miRNATAP -0.31 0.03643 NA
25 hsa-miR-335-3p ACVR1C 1.2 0.09389 1.69 0.1187 MirTarget -0.17 0.04358 NA
26 hsa-miR-7-1-3p ACVR1C 1.43 0.00471 1.69 0.1187 mirMAP -0.26 0.03453 NA
27 hsa-let-7i-5p ACVR2A 0.05 0.86971 -0.45 0.27609 miRNATAP -0.21 0.01256 NA
28 hsa-miR-142-3p ACVR2A 4.35 0 -0.45 0.27609 MirTarget; PITA; miRanda; miRNATAP -0.11 0.00043 NA
29 hsa-miR-181a-5p ACVR2A 1.26 0.00749 -0.45 0.27609 MirTarget; miRNATAP -0.1 0.03491 NA
30 hsa-miR-193b-5p ACVR2A 0.45 0.56588 -0.45 0.27609 MirTarget -0.13 1.0E-5 NA
31 hsa-miR-21-5p ACVR2A 2.65 0 -0.45 0.27609 miRNATAP -0.24 0.0004 NA
32 hsa-miR-27a-3p ACVR2A 1.76 0.00022 -0.45 0.27609 miRNATAP -0.14 0.00463 NA
33 hsa-miR-29a-3p ACVR2A -0.64 0.25192 -0.45 0.27609 miRNATAP -0.18 2.0E-5 NA
34 hsa-miR-29a-5p ACVR2A 0.07 0.88413 -0.45 0.27609 mirMAP; miRNATAP -0.21 0 NA
35 hsa-miR-29b-3p ACVR2A 0.67 0.23406 -0.45 0.27609 miRNATAP -0.18 1.0E-5 NA
36 hsa-miR-331-5p ACVR2A 1.03 0.02625 -0.45 0.27609 PITA -0.11 0.02976 NA
37 hsa-let-7b-3p ACVR2B 0.59 0.20051 -0.47 0.3473 MirTarget -0.23 0.00019 NA
38 hsa-let-7f-1-3p ACVR2B 1.62 0.00069 -0.47 0.3473 MirTarget -0.2 0.00088 NA
39 hsa-miR-142-5p ACVR2B 3.96 0 -0.47 0.3473 PITA -0.17 1.0E-5 NA
40 hsa-miR-342-5p ACVR2B 1.39 0.01536 -0.47 0.3473 miRNATAP -0.18 0.00022 NA
41 hsa-miR-455-3p ACVR2B 2.19 0.00137 -0.47 0.3473 miRNATAP -0.14 0.00069 NA
42 hsa-miR-455-5p ACVR2B -0.32 0.6163 -0.47 0.3473 PITA -0.16 0.00028 NA
43 hsa-let-7a-5p BMP2 0.15 0.64531 0.6 0.59614 TargetScan -0.43 0.03668 NA
44 hsa-miR-106a-5p BMP2 3.99 0 0.6 0.59614 miRNATAP -0.28 0.0002 NA
45 hsa-miR-362-3p BMP2 0.68 0.22615 0.6 0.59614 miRanda -0.39 0.0006 NA
46 hsa-miR-378c BMP2 0.45 0.49938 0.6 0.59614 miRNATAP -0.28 0.0034 NA
47 hsa-miR-429 BMP2 6.4 0 0.6 0.59614 miRNATAP -0.32 0.00011 NA
48 hsa-miR-142-3p BMP4 4.35 0 -1.95 0.0822 PITA; miRanda -0.38 2.0E-5 NA
49 hsa-miR-590-3p BMP4 2.35 0 -1.95 0.0822 miRanda -0.37 0.00319 NA
50 hsa-miR-125a-3p BMP7 -0.07 0.92074 2.47 0.14183 miRanda -0.6 0 NA
51 hsa-miR-30a-5p BMP7 -0.77 0.32049 2.47 0.14183 mirMAP; miRNATAP -0.84 0 NA
52 hsa-miR-338-3p BMP7 0.45 0.55849 2.47 0.14183 miRanda -0.68 0 NA
53 hsa-miR-616-5p BMP7 2.48 0.00318 2.47 0.14183 mirMAP -0.31 0.03095 NA
54 hsa-miR-142-3p BMP8A 4.35 0 -0.91 0.14941 miRNAWalker2 validate -0.15 0.00247 NA
55 hsa-miR-30e-3p BMP8A -0.04 0.93258 -0.91 0.14941 MirTarget -0.27 0.00121 NA
56 hsa-miR-326 BMP8A 1.77 0.03673 -0.91 0.14941 miRanda -0.12 0.00459 NA
57 hsa-miR-330-5p BMP8A 2.25 0.00028 -0.91 0.14941 miRanda -0.14 0.014 NA
58 hsa-miR-423-5p BMP8A 0.23 0.56535 -0.91 0.14941 MirTarget -0.18 0.04602 NA
59 hsa-miR-125a-3p BMP8B -0.07 0.92074 2.55 0.00041 miRanda -0.13 0.0158 NA
60 hsa-miR-125a-5p BMP8B -1.32 0.00714 2.55 0.00041 miRanda -0.22 0.00973 NA
61 hsa-miR-150-5p BMP8B 1.77 0.05938 2.55 0.00041 mirMAP -0.1 0.02078 NA
62 hsa-miR-181a-5p BMP8B 1.26 0.00749 2.55 0.00041 mirMAP -0.17 0.04884 NA
63 hsa-miR-181b-5p BMP8B 1.11 0.02734 2.55 0.00041 mirMAP -0.19 0.01825 NA
64 hsa-miR-181c-5p BMP8B -0.3 0.53753 2.55 0.00041 mirMAP -0.18 0.0358 NA
65 hsa-miR-26b-5p BMP8B 0.31 0.46163 2.55 0.00041 miRNAWalker2 validate -0.34 0.00051 NA
66 hsa-miR-455-5p BMP8B -0.32 0.6163 2.55 0.00041 miRanda -0.19 0.00365 NA
67 hsa-miR-942-5p BMPR1A 3.36 0 -1.12 0.02074 MirTarget -0.12 0.02233 NA
68 hsa-miR-142-5p BMPR1B 3.96 0 -1.52 0.34339 mirMAP -0.73 0 NA
69 hsa-miR-146b-5p BMPR1B 1.88 0.00074 -1.52 0.34339 miRanda -0.67 4.0E-5 NA
70 hsa-miR-150-5p BMPR1B 1.77 0.05938 -1.52 0.34339 MirTarget -0.47 0 NA
71 hsa-miR-205-5p BMPR1B 8.08 0 -1.52 0.34339 miRNATAP -0.31 0 NA
72 hsa-miR-23a-3p BMPR1B 0.93 0.01273 -1.52 0.34339 mirMAP -0.6 0.01516 NA
73 hsa-miR-23b-3p BMPR1B -0.58 0.19048 -1.52 0.34339 mirMAP -0.74 0.00035 NA
74 hsa-miR-24-3p BMPR1B 1.56 0.00052 -1.52 0.34339 miRNATAP -0.55 0.00635 NA
75 hsa-miR-374a-5p BMPR1B 0.28 0.45888 -1.52 0.34339 MirTarget -0.88 0.00036 NA
76 hsa-miR-590-3p BMPR1B 2.35 0 -1.52 0.34339 miRanda; mirMAP -0.55 0.00205 NA
77 hsa-miR-629-3p BMPR1B 3.48 0 -1.52 0.34339 MirTarget -0.42 0.00285 NA
78 hsa-let-7a-3p BMPR2 0.83 0.04681 -1.13 0.00109 MirTarget; miRNATAP -0.11 0.01644 NA
79 hsa-let-7f-1-3p BMPR2 1.62 0.00069 -1.13 0.00109 MirTarget -0.12 0.00286 NA
80 hsa-miR-106b-5p BMPR2 2.81 0 -1.13 0.00109 MirTarget; miRNATAP -0.12 0.00443 NA
81 hsa-miR-146b-3p BMPR2 1.35 0.00936 -1.13 0.00109 MirTarget; PITA -0.13 0.00059 NA
82 hsa-miR-148b-3p BMPR2 1.76 0 -1.13 0.00109 mirMAP -0.2 0.00099 NA
83 hsa-miR-16-2-3p BMPR2 3.8 0 -1.13 0.00109 mirMAP -0.15 6.0E-5 NA
84 hsa-miR-17-5p BMPR2 2.33 2.0E-5 -1.13 0.00109 miRNAWalker2 validate; MirTarget; TargetScan; miRNATAP -0.12 0.00049 NA
85 hsa-miR-19b-3p BMPR2 1.68 0.00086 -1.13 0.00109 miRNAWalker2 validate; MirTarget; miRNATAP -0.15 0.0001 NA
86 hsa-miR-20a-5p BMPR2 2.14 0.00018 -1.13 0.00109 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.11 0.00126 NA
87 hsa-miR-21-5p BMPR2 2.65 0 -1.13 0.00109 miRNAWalker2 validate; miRTarBase; MirTarget -0.12 0.03687 NA
88 hsa-miR-25-3p BMPR2 1.13 0.00311 -1.13 0.00109 miRNATAP -0.16 0.00181 NA
89 hsa-miR-30b-5p BMPR2 0.02 0.95322 -1.13 0.00109 mirMAP -0.17 0.00068 NA
90 hsa-miR-30e-5p BMPR2 0.78 0.03467 -1.13 0.00109 mirMAP -0.15 0.00461 NA
91 hsa-miR-32-5p BMPR2 2.93 0 -1.13 0.00109 miRNATAP -0.15 0.00016 NA
92 hsa-miR-590-3p BMPR2 2.35 0 -1.13 0.00109 MirTarget; miRanda; mirMAP; miRNATAP -0.18 0 NA
93 hsa-miR-590-5p BMPR2 1.51 0.00239 -1.13 0.00109 MirTarget; PITA; miRNATAP -0.15 0.00015 NA
94 hsa-miR-92a-3p BMPR2 1.88 1.0E-5 -1.13 0.00109 miRNAWalker2 validate; miRNATAP -0.2 1.0E-5 NA
95 hsa-miR-93-3p BMPR2 2.63 0 -1.13 0.00109 miRNAWalker2 validate -0.11 0.00334 NA
96 hsa-miR-93-5p BMPR2 2.66 0 -1.13 0.00109 miRNAWalker2 validate; MirTarget; miRNATAP -0.13 0.00184 NA
97 hsa-miR-103a-3p CD274 0.99 0.00468 2.22 0.05161 miRNAWalker2 validate -0.48 0.01013 NA
98 hsa-miR-106a-5p CD274 3.99 0 2.22 0.05161 MirTarget; miRNATAP -0.24 0.00245 NA
99 hsa-miR-182-5p CD274 5.87 0 2.22 0.05161 mirMAP -0.34 5.0E-5 NA
100 hsa-miR-200a-3p CD274 6.34 0 2.22 0.05161 MirTarget -0.35 1.0E-5 NA
101 hsa-miR-20b-5p CD274 4.57 5.0E-5 2.22 0.05161 MirTarget; miRNATAP -0.19 0.0007 24468585 These findings suggest that miR-20b -21 and -130b up-regulated in colorectal cancer through inhibiting the expression of PTEN result in B7-H1 over-expression in colorectal cancer
102 hsa-miR-324-5p CD274 1.31 0.01168 2.22 0.05161 miRanda -0.47 0.00014 NA
103 hsa-miR-429 CD274 6.4 0 2.22 0.05161 miRanda -0.41 0 NA
104 hsa-miR-497-5p CD274 -1.44 0.02251 2.22 0.05161 MirTarget -0.38 0.00018 NA
105 hsa-miR-93-5p CD274 2.66 0 2.22 0.05161 MirTarget; miRNATAP -0.46 0.00064 NA
106 hsa-miR-107 CDKN2B 1.49 0.00013 3.05 0.00021 PITA -0.45 0.00018 NA
107 hsa-miR-125a-3p CDKN2B -0.07 0.92074 3.05 0.00021 miRanda -0.28 1.0E-5 NA
108 hsa-miR-125a-5p CDKN2B -1.32 0.00714 3.05 0.00021 miRanda -0.61 0 NA
109 hsa-miR-126-5p CDKN2B -0.42 0.32997 3.05 0.00021 mirMAP -0.38 0.00047 NA
110 hsa-miR-19a-3p CDKN2B 2.17 0.00122 3.05 0.00021 mirMAP -0.14 0.04376 NA
111 hsa-miR-19b-3p CDKN2B 1.68 0.00086 3.05 0.00021 mirMAP -0.21 0.02389 NA
112 hsa-miR-217 CDKN2B -0.38 0.71741 3.05 0.00021 miRanda -0.15 0.00119 NA
113 hsa-miR-28-5p CDKN2B -0.82 0.02212 3.05 0.00021 miRanda -0.81 0 NA
114 hsa-miR-335-3p CDKN2B 1.2 0.09389 3.05 0.00021 mirMAP -0.23 0.00046 NA
115 hsa-miR-374b-5p CDKN2B -0.11 0.76489 3.05 0.00021 miRNAWalker2 validate -0.43 0.00059 NA
116 hsa-miR-375 CDKN2B 3.38 0.04499 3.05 0.00021 miRNAWalker2 validate; miRNATAP -0.14 0 NA
117 hsa-miR-450b-5p CDKN2B 0.45 0.41602 3.05 0.00021 mirMAP -0.27 0.00178 NA
118 hsa-miR-495-3p CDKN2B -1.28 0.09795 3.05 0.00021 MirTarget -0.18 0.00349 NA
119 hsa-miR-501-3p CDKN2B 1.72 0.00759 3.05 0.00021 PITA -0.38 0 NA
120 hsa-miR-501-5p CDKN2B 1.04 0.07772 3.05 0.00021 mirMAP -0.35 1.0E-5 NA
121 hsa-miR-502-3p CDKN2B -0.1 0.80889 3.05 0.00021 PITA -0.5 1.0E-5 NA
122 hsa-miR-576-5p CDKN2B 1.3 0.00649 3.05 0.00021 MirTarget -0.24 0.01358 NA
123 hsa-miR-582-5p CDKN2B 0.69 0.44776 3.05 0.00021 miRNATAP -0.14 0.00622 NA
124 hsa-miR-671-5p CDKN2B 1.49 0.00687 3.05 0.00021 PITA -0.35 3.0E-5 NA
125 hsa-miR-7-1-3p CDKN2B 1.43 0.00471 3.05 0.00021 MirTarget -0.36 0.00011 NA
126 hsa-let-7f-5p CHRD 0.97 0.02403 -4.87 0 MirTarget; miRNATAP -0.34 0.01715 NA
127 hsa-let-7g-3p CHRD 2.1 5.0E-5 -4.87 0 MirTarget -0.24 0.03692 NA
128 hsa-miR-21-3p CREBBP 3.5 0 -0.4 0.18067 MirTarget -0.14 0 NA
129 hsa-miR-590-3p CREBBP 2.35 0 -0.4 0.18067 PITA; miRanda; mirMAP; miRNATAP -0.1 0.00219 NA
130 hsa-let-7d-5p DCN 0.83 0.0127 -5.58 0 MirTarget -0.69 0.00017 NA
131 hsa-let-7g-5p DCN 0.86 0.00648 -5.58 0 MirTarget -0.51 0.00996 NA
132 hsa-miR-3065-5p DCN 2.14 0.06094 -5.58 0 mirMAP -0.14 0.03582 NA
133 hsa-miR-374b-3p DCN 0.5 0.34334 -5.58 0 MirTarget -0.28 0.01477 NA
134 hsa-miR-421 DCN 1.98 0.00092 -5.58 0 miRanda -0.28 0.00668 NA
135 hsa-miR-501-5p DCN 1.04 0.07772 -5.58 0 mirMAP -0.36 0.00054 NA
136 hsa-miR-590-3p DCN 2.35 0 -5.58 0 MirTarget; PITA; miRanda; mirMAP -0.42 0.00046 NA
137 hsa-miR-7-1-3p DCN 1.43 0.00471 -5.58 0 mirMAP -0.33 0.00582 NA
138 hsa-let-7a-5p E2F5 0.15 0.64531 -0.64 0.41617 MirTarget; TargetScan; miRNATAP -0.33 0.02249 NA
139 hsa-let-7b-5p E2F5 -0.19 0.65188 -0.64 0.41617 miRNAWalker2 validate; MirTarget; miRNATAP -0.28 0.01021 NA
140 hsa-let-7f-5p E2F5 0.97 0.02403 -0.64 0.41617 MirTarget; miRNATAP -0.35 0.00066 NA
141 hsa-let-7i-5p E2F5 0.05 0.86971 -0.64 0.41617 MirTarget; miRNATAP -0.49 0.00194 NA
142 hsa-miR-1-3p E2F5 -3.85 1.0E-5 -0.64 0.41617 MirTarget -0.15 0.00306 NA
143 hsa-miR-142-3p E2F5 4.35 0 -0.64 0.41617 miRanda -0.17 0.00689 NA
144 hsa-miR-199b-5p E2F5 -0.54 0.47689 -0.64 0.41617 miRanda -0.13 0.03312 NA
145 hsa-miR-205-5p E2F5 8.08 0 -0.64 0.41617 miRNAWalker2 validate; miRTarBase; miRNATAP -0.18 0 21454583 The expression levels of E2F1 and E2F5 were correlated inversely with that of miR-205 in melanoma cell lines; miR-205 significantly suppressed the luciferase activity of reporter plasmids containing the 3'-UTR sequences complementary to either E2F1 or E2F5; Overexpression of miR-205 in melanoma cells reduced E2F1 and E2F5 protein levels
146 hsa-miR-34c-5p E2F5 2.65 0.01574 -0.64 0.41617 MirTarget; PITA; miRanda; miRNATAP -0.16 9.0E-5 NA
147 hsa-miR-148a-3p EP300 1.1 0.05204 0.22 0.57893 miRNATAP -0.1 0.00975 NA
148 hsa-miR-26b-5p EP300 0.31 0.46163 0.22 0.57893 miRNAWalker2 validate; miRNATAP -0.13 0.01396 NA
149 hsa-miR-30c-5p EP300 0.39 0.34861 0.22 0.57893 miRNAWalker2 validate -0.19 0.0009 NA
150 hsa-miR-339-5p EP300 1.23 0.03075 0.22 0.57893 miRanda -0.2 0 NA
NumGOOverlapSizeP ValueAdj. P Value
1 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 36 190 9.482e-57 4.412e-53
2 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 31 207 7.085e-45 1.648e-41
3 RESPONSE TO GROWTH FACTOR 36 475 1.184e-41 1.837e-38
4 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 39 689 1.34e-40 1.559e-37
5 REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 21 60 1.1e-38 1.023e-35
6 RESPONSE TO BMP 23 94 3.037e-38 2.018e-35
7 CELLULAR RESPONSE TO BMP STIMULUS 23 94 3.037e-38 2.018e-35
8 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 22 100 2.055e-35 1.195e-32
9 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 39 1008 3.475e-34 1.797e-31
10 POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 18 48 8.381e-34 3.899e-31
11 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 45 1784 1.672e-32 7.074e-30
12 SMAD PROTEIN SIGNAL TRANSDUCTION 18 56 2.391e-32 9.272e-30
13 RESPONSE TO ENDOGENOUS STIMULUS 42 1450 3.431e-32 1.228e-29
14 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 19 95 1.099e-29 3.653e-27
15 REGULATION OF OSSIFICATION 22 178 1.771e-29 5.493e-27
16 REGULATION OF OSTEOBLAST DIFFERENTIATION 19 112 3.299e-28 9.595e-26
17 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 42 1848 6.382e-28 1.747e-25
18 POSITIVE REGULATION OF GENE EXPRESSION 41 1733 9.08e-28 2.347e-25
19 REGULATION OF PHOSPHORUS METABOLIC PROCESS 39 1618 2.092e-26 5.122e-24
20 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 19 144 5.311e-26 1.236e-23
21 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 39 1672 7.092e-26 1.571e-23
22 ORGAN MORPHOGENESIS 31 841 1.104e-25 2.335e-23
23 TUBE DEVELOPMENT 27 552 2.336e-25 4.726e-23
24 TISSUE DEVELOPMENT 37 1518 5.931e-25 1.15e-22
25 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 39 1805 1.207e-24 2.16e-22
26 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 32 1004 1.205e-24 2.16e-22
27 REGULATION OF PROTEIN MODIFICATION PROCESS 38 1710 2.587e-24 4.459e-22
28 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 35 1395 8.629e-24 1.434e-21
29 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 31 983 1.182e-23 1.897e-21
30 SKELETAL SYSTEM DEVELOPMENT 24 455 3.403e-23 5.278e-21
31 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 32 1142 6.254e-23 9.387e-21
32 REGULATION OF CELL DIFFERENTIATION 35 1492 8.017e-23 1.166e-20
33 POSITIVE REGULATION OF OSSIFICATION 15 84 1.048e-22 1.477e-20
34 ACTIVIN RECEPTOR SIGNALING PATHWAY 11 22 1.201e-22 1.643e-20
35 EPITHELIUM DEVELOPMENT 29 945 1.17e-21 1.512e-19
36 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 34 1492 1.152e-21 1.512e-19
37 PATTERN SPECIFICATION PROCESS 22 418 3.395e-21 4.27e-19
38 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 27 801 4.148e-21 5.079e-19
39 EMBRYO DEVELOPMENT 28 894 4.341e-21 5.179e-19
40 REGULATION OF CELL DEATH 33 1472 1.027e-20 1.194e-18
41 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 30 1135 1.266e-20 1.437e-18
42 REGULATION OF CELL PROLIFERATION 33 1496 1.692e-20 1.875e-18
43 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 18 229 1.803e-20 1.951e-18
44 HEART DEVELOPMENT 22 466 3.559e-20 3.761e-18
45 CONNECTIVE TISSUE DEVELOPMENT 17 194 3.637e-20 3.761e-18
46 GROWTH 21 410 5.623e-20 5.688e-18
47 UROGENITAL SYSTEM DEVELOPMENT 19 299 7.782e-20 7.704e-18
48 NEGATIVE REGULATION OF CELL PROLIFERATION 24 643 1.125e-19 1.09e-17
49 POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 11 38 1.969e-19 1.869e-17
50 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 28 1036 2.19e-19 1.998e-17
51 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 28 1036 2.19e-19 1.998e-17
52 POSITIVE REGULATION OF RESPONSE TO STIMULUS 35 1929 3.524e-19 3.154e-17
53 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 12 60 5.879e-19 5.161e-17
54 CELL DEVELOPMENT 31 1426 6.458e-19 5.565e-17
55 CARTILAGE DEVELOPMENT 15 147 7.202e-19 6.093e-17
56 MESODERM DEVELOPMENT 14 118 1.327e-18 1.102e-16
57 GASTRULATION 15 155 1.628e-18 1.329e-16
58 MESONEPHROS DEVELOPMENT 13 90 1.709e-18 1.371e-16
59 POSITIVE REGULATION OF CELL DIFFERENTIATION 25 823 2.186e-18 1.724e-16
60 POSITIVE REGULATION OF CELL COMMUNICATION 31 1532 5.057e-18 3.922e-16
61 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 13 102 9.447e-18 7.206e-16
62 CARDIOVASCULAR SYSTEM DEVELOPMENT 24 788 1.196e-17 8.83e-16
63 CIRCULATORY SYSTEM DEVELOPMENT 24 788 1.196e-17 8.83e-16
64 EMBRYONIC MORPHOGENESIS 21 539 1.512e-17 1.099e-15
65 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 26 1021 2.783e-17 1.992e-15
66 REGULATION OF CELL DEVELOPMENT 24 836 4.573e-17 3.224e-15
67 PROTEIN PHOSPHORYLATION 25 944 5.549e-17 3.854e-15
68 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 13 121 9.465e-17 6.477e-15
69 REGULATION OF CELLULAR COMPONENT MOVEMENT 23 771 1.072e-16 7.226e-15
70 KIDNEY EPITHELIUM DEVELOPMENT 13 125 1.463e-16 9.723e-15
71 MESODERM MORPHOGENESIS 11 66 1.639e-16 1.074e-14
72 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 12 99 3.529e-16 2.249e-14
73 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 12 99 3.529e-16 2.249e-14
74 REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 11 75 7.31e-16 4.597e-14
75 NEGATIVE REGULATION OF CELL COMMUNICATION 26 1192 1.164e-15 7.224e-14
76 REGIONALIZATION 16 311 2.593e-15 1.587e-13
77 TISSUE MORPHOGENESIS 19 533 3.528e-15 2.132e-13
78 RESPONSE TO ORGANIC CYCLIC COMPOUND 23 917 4.494e-15 2.681e-13
79 PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 7 13 4.638e-15 2.732e-13
80 GLAND DEVELOPMENT 17 395 5.91e-15 3.438e-13
81 REGULATION OF CARTILAGE DEVELOPMENT 10 63 7.115e-15 4.087e-13
82 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 21 740 8.477e-15 4.81e-13
83 EMBRYONIC ORGAN DEVELOPMENT 17 406 9.28e-15 5.202e-13
84 PHOSPHORYLATION 25 1228 2.414e-14 1.337e-12
85 RHYTHMIC PROCESS 15 298 2.959e-14 1.62e-12
86 POSITIVE REGULATION OF CELL DEATH 19 605 3.467e-14 1.876e-12
87 MESENCHYME DEVELOPMENT 13 190 3.62e-14 1.936e-12
88 NEGATIVE REGULATION OF CELL DIFFERENTIATION 19 609 3.902e-14 2.063e-12
89 POSITIVE REGULATION OF CELL PROLIFERATION 21 814 5.483e-14 2.866e-12
90 FORMATION OF PRIMARY GERM LAYER 11 110 5.833e-14 3.015e-12
91 REGULATION OF BMP SIGNALING PATHWAY 10 77 5.897e-14 3.015e-12
92 SKELETAL SYSTEM MORPHOGENESIS 13 201 7.499e-14 3.793e-12
93 BONE DEVELOPMENT 12 156 9.324e-14 4.665e-12
94 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 22 957 1.221e-13 6.045e-12
95 POSITIVE REGULATION OF LOCOMOTION 16 420 2.726e-13 1.335e-11
96 REGULATION OF EPITHELIAL CELL PROLIFERATION 14 285 3.294e-13 1.597e-11
97 MESENCHYMAL CELL DIFFERENTIATION 11 134 5.298e-13 2.541e-11
98 NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 9 66 7.275e-13 3.419e-11
99 NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 9 66 7.275e-13 3.419e-11
100 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 9 67 8.382e-13 3.9e-11
101 REGULATION OF CELL CYCLE 21 949 1.063e-12 4.897e-11
102 ANTERIOR POSTERIOR PATTERN SPECIFICATION 12 194 1.267e-12 5.779e-11
103 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 16 465 1.286e-12 5.808e-11
104 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 17 554 1.423e-12 6.369e-11
105 ODONTOGENESIS 10 105 1.445e-12 6.405e-11
106 RESPIRATORY SYSTEM DEVELOPMENT 12 197 1.52e-12 6.672e-11
107 DIGESTIVE SYSTEM DEVELOPMENT 11 148 1.59e-12 6.915e-11
108 NEGATIVE REGULATION OF GENE EXPRESSION 25 1493 1.938e-12 8.349e-11
109 REGULATION OF MAPK CASCADE 18 660 2.005e-12 8.557e-11
110 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 25 1517 2.756e-12 1.166e-10
111 RESPONSE TO LIPID 20 888 3.061e-12 1.272e-10
112 REGULATION OF STEM CELL DIFFERENTIATION 10 113 3.049e-12 1.272e-10
113 HEART MORPHOGENESIS 12 212 3.622e-12 1.491e-10
114 POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 7 29 4.05e-12 1.653e-10
115 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 22 1152 4.942e-12 2e-10
116 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 17 602 5.334e-12 2.14e-10
117 REGULATION OF BINDING 13 283 5.895e-12 2.344e-10
118 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 7 34 1.378e-11 5.435e-10
119 REGULATION OF ORGAN MORPHOGENESIS 12 242 1.714e-11 6.7e-10
120 POSITIVE REGULATION OF CELL DEVELOPMENT 15 472 2.213e-11 8.582e-10
121 STEM CELL DIFFERENTIATION 11 190 2.436e-11 9.367e-10
122 OSSIFICATION 12 251 2.624e-11 1.001e-09
123 TUBE MORPHOGENESIS 13 323 3.088e-11 1.168e-09
124 MESENCHYME MORPHOGENESIS 7 38 3.201e-11 1.201e-09
125 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 14 404 3.602e-11 1.341e-09
126 SENSORY ORGAN DEVELOPMENT 15 493 4.083e-11 1.508e-09
127 NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 7 40 4.704e-11 1.724e-09
128 NEGATIVE REGULATION OF OSSIFICATION 8 69 5.701e-11 2.073e-09
129 HEAD DEVELOPMENT 17 709 6.945e-11 2.505e-09
130 EMBRYONIC ORGAN MORPHOGENESIS 12 279 8.951e-11 3.197e-09
131 NEGATIVE REGULATION OF CELL CYCLE 14 433 9e-11 3.197e-09
132 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 20 1087 1.164e-10 4.103e-09
133 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 22 1360 1.249e-10 4.37e-09
134 REGULATION OF APOPTOTIC SIGNALING PATHWAY 13 363 1.313e-10 4.559e-09
135 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 26 1977 1.369e-10 4.718e-09
136 REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY 6 25 1.57e-10 5.37e-09
137 RESPONSE TO OXYGEN CONTAINING COMPOUND 22 1381 1.676e-10 5.691e-09
138 NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 8 80 1.922e-10 6.481e-09
139 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 9 122 2.081e-10 6.965e-09
140 NEUROGENESIS 22 1402 2.236e-10 7.431e-09
141 POSITIVE REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS 5 12 2.412e-10 7.959e-09
142 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 7 50 2.457e-10 8.052e-09
143 VASCULATURE DEVELOPMENT 14 469 2.565e-10 8.347e-09
144 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS 6 27 2.61e-10 8.434e-09
145 CARDIAC SEPTUM DEVELOPMENT 8 85 3.151e-10 9.973e-09
146 PALATE DEVELOPMENT 8 85 3.151e-10 9.973e-09
147 IN UTERO EMBRYONIC DEVELOPMENT 12 311 3.121e-10 9.973e-09
148 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 9 129 3.434e-10 1.08e-08
149 REPRODUCTION 21 1297 3.698e-10 1.155e-08
150 IMMUNE SYSTEM DEVELOPMENT 15 582 4.111e-10 1.275e-08
151 REPRODUCTIVE SYSTEM DEVELOPMENT 13 408 5.504e-10 1.696e-08
152 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 8 93 6.534e-10 2e-08
153 EMBRYONIC PATTERN SPECIFICATION 7 58 7.248e-10 2.204e-08
154 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 12 337 7.798e-10 2.356e-08
155 ENDOCARDIAL CUSHION DEVELOPMENT 6 32 7.89e-10 2.369e-08
156 GLAND MORPHOGENESIS 8 97 9.178e-10 2.738e-08
157 HEART VALVE DEVELOPMENT 6 34 1.165e-09 3.453e-08
158 REGULATION OF EPIDERMIS DEVELOPMENT 7 63 1.317e-09 3.854e-08
159 REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS 5 16 1.317e-09 3.854e-08
160 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 9 153 1.571e-09 4.569e-08
161 POSITIVE REGULATION OF PROTEIN IMPORT 8 104 1.607e-09 4.644e-08
162 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 14 541 1.633e-09 4.662e-08
163 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 14 541 1.633e-09 4.662e-08
164 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 9 154 1.664e-09 4.722e-08
165 CELL DEATH 18 1001 1.783e-09 5.029e-08
166 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 10 218 2.043e-09 5.728e-08
167 RESPONSE TO HORMONE 17 893 2.373e-09 6.612e-08
168 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 9 162 2.604e-09 7.212e-08
169 CELL PROLIFERATION 15 672 2.934e-09 8.078e-08
170 CELL FATE COMMITMENT 10 227 3.019e-09 8.263e-08
171 MORPHOGENESIS OF A BRANCHING STRUCTURE 9 167 3.404e-09 9.261e-08
172 APPENDAGE DEVELOPMENT 9 169 3.779e-09 1.016e-07
173 LIMB DEVELOPMENT 9 169 3.779e-09 1.016e-07
174 REGULATION OF VASCULATURE DEVELOPMENT 10 233 3.88e-09 1.038e-07
175 POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 9 171 4.191e-09 1.114e-07
176 NEGATIVE REGULATION OF GROWTH 10 236 4.388e-09 1.16e-07
177 ARTERY DEVELOPMENT 7 75 4.582e-09 1.205e-07
178 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 22 1656 5.108e-09 1.335e-07
179 MORPHOGENESIS OF AN EPITHELIUM 12 400 5.383e-09 1.392e-07
180 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 8 121 5.376e-09 1.392e-07
181 EPITHELIAL CELL DIFFERENTIATION 13 495 5.677e-09 1.459e-07
182 RESPONSE TO STEROID HORMONE 13 497 5.957e-09 1.523e-07
183 ENDOCRINE SYSTEM DEVELOPMENT 8 123 6.122e-09 1.557e-07
184 LUNG MORPHOGENESIS 6 45 6.862e-09 1.735e-07
185 EYE DEVELOPMENT 11 326 7.453e-09 1.875e-07
186 REGULATION OF PROTEIN IMPORT 9 183 7.593e-09 1.899e-07
187 EMBRYONIC CRANIAL SKELETON MORPHOGENESIS 6 46 7.872e-09 1.959e-07
188 REGULATION OF PHOSPHATASE ACTIVITY 8 128 8.392e-09 2.077e-07
189 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 13 513 8.689e-09 2.139e-07
190 DEVELOPMENTAL GROWTH 11 333 9.286e-09 2.274e-07
191 LOCOMOTION 18 1114 9.548e-09 2.326e-07
192 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 8 131 1.008e-08 2.442e-07
193 DIGESTIVE TRACT MORPHOGENESIS 6 48 1.026e-08 2.474e-07
194 REGULATION OF CELL ADHESION 14 629 1.114e-08 2.671e-07
195 REGULATION OF GROWTH 14 633 1.206e-08 2.878e-07
196 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 15 750 1.283e-08 3.045e-07
197 NEGATIVE REGULATION OF CELL DEATH 16 872 1.296e-08 3.045e-07
198 CENTRAL NERVOUS SYSTEM DEVELOPMENT 16 872 1.296e-08 3.045e-07
199 SEX DIFFERENTIATION 10 266 1.376e-08 3.218e-07
200 OVULATION CYCLE PROCESS 7 88 1.418e-08 3.299e-07
201 DORSAL VENTRAL PATTERN FORMATION 7 91 1.794e-08 4.153e-07
202 RESPONSE TO ABIOTIC STIMULUS 17 1024 1.821e-08 4.195e-07
203 MUSCLE TISSUE DEVELOPMENT 10 275 1.887e-08 4.326e-07
204 REGULATION OF KINASE ACTIVITY 15 776 2.019e-08 4.605e-07
205 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 11 360 2.072e-08 4.68e-07
206 REGULATION OF CELL MORPHOGENESIS 13 552 2.069e-08 4.68e-07
207 CARDIAC CHAMBER DEVELOPMENT 8 144 2.12e-08 4.766e-07
208 ACTIVATION OF PROTEIN KINASE ACTIVITY 10 279 2.164e-08 4.841e-07
209 REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION 5 27 2.368e-08 5.271e-07
210 CRANIAL SKELETAL SYSTEM DEVELOPMENT 6 55 2.381e-08 5.276e-07
211 EPITHELIAL TO MESENCHYMAL TRANSITION 6 56 2.66e-08 5.867e-07
212 GASTRULATION WITH MOUTH FORMING SECOND 5 28 2.875e-08 6.311e-07
213 REGULATION OF HEART MORPHOGENESIS 5 29 3.466e-08 7.571e-07
214 CELL CYCLE ARREST 8 154 3.583e-08 7.791e-07
215 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 9 220 3.752e-08 8.119e-07
216 PROTEIN LOCALIZATION TO NUCLEUS 8 156 3.962e-08 8.535e-07
217 REGULATION OF TRANSFERASE ACTIVITY 16 946 4.04e-08 8.663e-07
218 CHONDROCYTE DIFFERENTIATION 6 60 4.061e-08 8.667e-07
219 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 7 103 4.26e-08 9.05e-07
220 REGULATION OF PROTEIN LOCALIZATION 16 950 4.284e-08 9.06e-07
221 REGULATION OF DEPHOSPHORYLATION 8 158 4.375e-08 9.212e-07
222 REGULATION OF EPITHELIAL CELL MIGRATION 8 166 6.421e-08 1.346e-06
223 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 13 616 7.465e-08 1.558e-06
224 REGULATION OF CELLULAR LOCALIZATION 18 1277 7.751e-08 1.61e-06
225 ORGAN FORMATION 5 34 8.019e-08 1.651e-06
226 REGULATION OF MESENCHYMAL CELL PROLIFERATION 5 34 8.019e-08 1.651e-06
227 OVULATION CYCLE 7 113 8.095e-08 1.659e-06
228 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 12 514 8.532e-08 1.741e-06
229 ORGAN GROWTH 6 68 8.7e-08 1.768e-06
230 NEURON DIFFERENTIATION 15 874 9.629e-08 1.948e-06
231 SPECIFICATION OF SYMMETRY 7 117 1.029e-07 2.073e-06
232 ENDODERM DEVELOPMENT 6 71 1.13e-07 2.266e-06
233 CELL CYCLE 18 1316 1.22e-07 2.436e-06
234 REGULATION OF TRANSPORT 21 1804 1.264e-07 2.512e-06
235 MULTICELLULAR ORGANISM REPRODUCTION 14 768 1.333e-07 2.639e-06
236 REGULATION OF HAIR FOLLICLE DEVELOPMENT 4 15 1.35e-07 2.661e-06
237 ODONTOGENESIS OF DENTIN CONTAINING TOOTH 6 75 1.572e-07 3.087e-06
238 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 9 262 1.669e-07 3.264e-06
239 OSTEOBLAST DIFFERENTIATION 7 126 1.712e-07 3.333e-06
240 MYELOID CELL DIFFERENTIATION 8 189 1.747e-07 3.387e-06
241 REGULATION OF CELLULAR PROTEIN LOCALIZATION 12 552 1.843e-07 3.559e-06
242 REGULATION OF HOMEOSTATIC PROCESS 11 447 1.857e-07 3.571e-06
243 REGULATION OF NEURON DIFFERENTIATION 12 554 1.916e-07 3.669e-06
244 BONE MORPHOGENESIS 6 79 2.149e-07 4.098e-06
245 REGULATION OF CYTOKINE PRODUCTION 12 563 2.278e-07 4.326e-06
246 PITUITARY GLAND DEVELOPMENT 5 42 2.403e-07 4.527e-06
247 NEGATIVE REGULATION OF BMP SIGNALING PATHWAY 5 42 2.403e-07 4.527e-06
248 CELL CYCLE PROCESS 16 1081 2.509e-07 4.708e-06
249 REGULATION OF IMMUNE SYSTEM PROCESS 18 1403 3.168e-07 5.92e-06
250 ENDOCHONDRAL BONE MORPHOGENESIS 5 45 3.426e-07 6.376e-06
251 POSITIVE REGULATION OF CELL ADHESION 10 376 3.493e-07 6.475e-06
252 CARDIAC MUSCLE TISSUE DEVELOPMENT 7 140 3.514e-07 6.489e-06
253 ATRIOVENTRICULAR VALVE DEVELOPMENT 4 19 3.796e-07 6.981e-06
254 REGULATION OF CHONDROCYTE DIFFERENTIATION 5 46 3.834e-07 7.023e-06
255 NEGATIVE REGULATION OF CYTOKINE PRODUCTION 8 211 4.049e-07 7.389e-06
256 EPITHELIAL CELL PROLIFERATION 6 89 4.38e-07 7.961e-06
257 AXIS SPECIFICATION 6 90 4.681e-07 8.442e-06
258 ENDOTHELIUM DEVELOPMENT 6 90 4.681e-07 8.442e-06
259 NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY 4 20 4.733e-07 8.503e-06
260 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 8 216 4.837e-07 8.657e-06
261 MALE SEX DIFFERENTIATION 7 148 5.124e-07 9.134e-06
262 NEGATIVE REGULATION OF CELL DEVELOPMENT 9 303 5.674e-07 1.008e-05
263 IMMUNE SYSTEM PROCESS 21 1984 6.237e-07 1.103e-05
264 REGULATION OF PROTEIN TARGETING 9 307 6.331e-07 1.116e-05
265 CARDIOCYTE DIFFERENTIATION 6 96 6.865e-07 1.205e-05
266 REGULATION OF HAIR CYCLE 4 22 7.111e-07 1.23e-05
267 ENDOCARDIAL CUSHION MORPHOGENESIS 4 22 7.111e-07 1.23e-05
268 RESPONSE TO EXTERNAL STIMULUS 20 1821 7.084e-07 1.23e-05
269 RESPONSE TO OXYGEN LEVELS 9 311 7.052e-07 1.23e-05
270 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 6 98 7.755e-07 1.336e-05
271 MESONEPHRIC TUBULE MORPHOGENESIS 5 53 7.887e-07 1.349e-05
272 POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 5 53 7.887e-07 1.349e-05
273 VENTRICULAR SEPTUM DEVELOPMENT 5 54 8.67e-07 1.478e-05
274 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 6 100 8.738e-07 1.484e-05
275 CELLULAR COMPONENT MORPHOGENESIS 14 900 9.038e-07 1.529e-05
276 NEGATIVE REGULATION OF PHOSPHORYLATION 10 422 9.994e-07 1.685e-05
277 RESPONSE TO STEROL 4 24 1.028e-06 1.721e-05
278 CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 4 24 1.028e-06 1.721e-05
279 REGULATION OF MUSCLE TISSUE DEVELOPMENT 6 103 1.04e-06 1.729e-05
280 REGULATION OF MUSCLE ORGAN DEVELOPMENT 6 103 1.04e-06 1.729e-05
281 REGULATION OF PROTEIN BINDING 7 168 1.203e-06 1.985e-05
282 RESPONSE TO CARBOHYDRATE 7 168 1.203e-06 1.985e-05
283 REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION 4 25 1.221e-06 2.007e-05
284 REGULATION OF GLIAL CELL DIFFERENTIATION 5 59 1.355e-06 2.221e-05
285 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 10 437 1.37e-06 2.236e-05
286 NEGATIVE REGULATION OF MOLECULAR FUNCTION 15 1079 1.411e-06 2.296e-05
287 NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION 4 26 1.439e-06 2.317e-05
288 NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT 4 26 1.439e-06 2.317e-05
289 POSITIVE REGULATION OF TRANSPORT 14 936 1.438e-06 2.317e-05
290 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 5 60 1.475e-06 2.367e-05
291 CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM 8 252 1.544e-06 2.469e-05
292 EMBRYONIC DIGIT MORPHOGENESIS 5 61 1.603e-06 2.536e-05
293 OVARIAN FOLLICLE DEVELOPMENT 5 61 1.603e-06 2.536e-05
294 POSITIVE REGULATION OF STEM CELL PROLIFERATION 5 61 1.603e-06 2.536e-05
295 POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS 6 111 1.614e-06 2.546e-05
296 REGULATION OF ASTROCYTE DIFFERENTIATION 4 27 1.685e-06 2.641e-05
297 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 4 27 1.685e-06 2.641e-05
298 RESPONSE TO WOUNDING 11 563 1.802e-06 2.813e-05
299 POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 8 258 1.84e-06 2.864e-05
300 NEPHRON DEVELOPMENT 6 115 1.986e-06 3.08e-05
301 CELLULAR RESPONSE TO LIPID 10 457 2.046e-06 3.159e-05
302 RESPONSE TO KETONE 7 182 2.054e-06 3.159e-05
303 REGULATION OF CELLULAR AMIDE METABOLIC PROCESS 9 354 2.057e-06 3.159e-05
304 FEMALE SEX DIFFERENTIATION 6 116 2.089e-06 3.197e-05
305 FOREBRAIN DEVELOPMENT 9 357 2.205e-06 3.363e-05
306 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 16 1275 2.241e-06 3.407e-05
307 RESPONSE TO ALCOHOL 9 362 2.471e-06 3.745e-05
308 REGULATION OF MITOTIC CELL CYCLE 10 468 2.53e-06 3.822e-05
309 NEURON FATE COMMITMENT 5 67 2.563e-06 3.859e-05
310 BLOOD VESSEL MORPHOGENESIS 9 364 2.584e-06 3.879e-05
311 REGULATION OF CELL JUNCTION ASSEMBLY 5 68 2.759e-06 4.115e-05
312 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 5 68 2.759e-06 4.115e-05
313 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 6 122 2.803e-06 4.166e-05
314 POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 9 370 2.954e-06 4.363e-05
315 POSITIVE REGULATION OF SECRETION 9 370 2.954e-06 4.363e-05
316 REGULATION OF HORMONE LEVELS 10 478 3.054e-06 4.497e-05
317 NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS 9 372 3.086e-06 4.53e-05
318 REGULATION OF CYTOPLASMIC TRANSPORT 10 481 3.229e-06 4.724e-05
319 POSITIVE REGULATION OF KINASE ACTIVITY 10 482 3.289e-06 4.797e-05
320 SALIVARY GLAND DEVELOPMENT 4 32 3.412e-06 4.93e-05
321 POSITIVE REGULATION OF BMP SIGNALING PATHWAY 4 32 3.412e-06 4.93e-05
322 POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT 4 32 3.412e-06 4.93e-05
323 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 13 867 3.538e-06 5.097e-05
324 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 8 282 3.56e-06 5.113e-05
325 ENDOTHELIAL CELL DIFFERENTIATION 5 72 3.667e-06 5.25e-05
326 NEGATIVE REGULATION OF MITOTIC CELL CYCLE 7 199 3.712e-06 5.298e-05
327 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 9 381 3.75e-06 5.335e-05
328 EMBRYONIC DIGESTIVE TRACT DEVELOPMENT 4 33 3.873e-06 5.48e-05
329 NUCLEAR IMPORT 6 129 3.875e-06 5.48e-05
330 PROTEIN KINASE B SIGNALING 4 34 4.378e-06 6.174e-05
331 REGULATION OF PROTEIN SECRETION 9 389 4.438e-06 6.239e-05
332 NEURAL CREST CELL DIFFERENTIATION 5 75 4.49e-06 6.292e-05
333 REGULATION OF INTRACELLULAR TRANSPORT 11 621 4.621e-06 6.456e-05
334 ANGIOGENESIS 8 293 4.72e-06 6.575e-05
335 MULTI ORGANISM REPRODUCTIVE PROCESS 13 891 4.765e-06 6.619e-05
336 DIENCEPHALON DEVELOPMENT 5 77 5.114e-06 7.082e-05
337 POSITIVE REGULATION OF HAIR CYCLE 3 11 5.306e-06 7.305e-05
338 NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 3 11 5.306e-06 7.305e-05
339 RENAL TUBULE DEVELOPMENT 5 78 5.451e-06 7.459e-05
340 SOMITE DEVELOPMENT 5 78 5.451e-06 7.459e-05
341 NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT 4 36 5.534e-06 7.53e-05
342 NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 4 36 5.534e-06 7.53e-05
343 REGULATION OF CELLULAR COMPONENT BIOGENESIS 12 767 5.771e-06 7.829e-05
344 NEGATIVE REGULATION OF GLIOGENESIS 4 37 6.19e-06 8.373e-05
345 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 9 406 6.271e-06 8.458e-05
346 POSITIVE REGULATION OF HOMEOSTATIC PROCESS 7 216 6.364e-06 8.559e-05
347 POSITIVE REGULATION OF NEURON DIFFERENTIATION 8 306 6.489e-06 8.701e-05
348 METANEPHROS DEVELOPMENT 5 81 6.566e-06 8.754e-05
349 POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION 5 81 6.566e-06 8.754e-05
350 RESPONSE TO ESTROGEN 7 218 6.76e-06 8.987e-05
351 KIDNEY MORPHOGENESIS 5 82 6.975e-06 9.246e-05
352 REGULATION OF ENDOTHELIAL CELL DEVELOPMENT 3 12 7.059e-06 9.252e-05
353 ANATOMICAL STRUCTURE REGRESSION 3 12 7.059e-06 9.252e-05
354 TRACHEA MORPHOGENESIS 3 12 7.059e-06 9.252e-05
355 REGULATION OF ESTABLISHMENT OF ENDOTHELIAL BARRIER 3 12 7.059e-06 9.252e-05
356 CELLULAR RESPONSE TO STRESS 17 1565 7.091e-06 9.268e-05
357 CELLULAR MACROMOLECULE LOCALIZATION 15 1234 7.322e-06 9.543e-05
358 REGULATION OF HEMOPOIESIS 8 314 7.835e-06 0.0001018
359 REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 6 147 8.226e-06 0.0001066
360 REGULATION OF MAP KINASE ACTIVITY 8 319 8.79e-06 0.0001136
361 NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION 3 13 9.155e-06 0.0001167
362 REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT 3 13 9.155e-06 0.0001167
363 MESENCHYMAL CELL PROLIFERATION 3 13 9.155e-06 0.0001167
364 REGULATION OF GONADOTROPIN SECRETION 3 13 9.155e-06 0.0001167
365 REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY 3 13 9.155e-06 0.0001167
366 TISSUE REMODELING 5 87 9.328e-06 0.0001186
367 MYELOID CELL HOMEOSTASIS 5 88 9.865e-06 0.0001247
368 REGULATION OF STEM CELL PROLIFERATION 5 88 9.865e-06 0.0001247
369 REGULATION OF LEUKOCYTE DIFFERENTIATION 7 232 1.015e-05 0.0001279
370 SEGMENTATION 5 89 1.043e-05 0.0001311
371 REGULATION OF GLIOGENESIS 5 90 1.101e-05 0.0001381
372 PROTEIN IMPORT 6 155 1.114e-05 0.0001393
373 POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 3 14 1.163e-05 0.0001431
374 REGULATION OF GLOMERULUS DEVELOPMENT 3 14 1.163e-05 0.0001431
375 EMBRYONIC SKELETAL JOINT DEVELOPMENT 3 14 1.163e-05 0.0001431
376 PROTEIN LOCALIZATION TO ORGANELLE 10 556 1.152e-05 0.0001431
377 PROTEIN LOCALIZATION 18 1805 1.163e-05 0.0001431
378 RESPONSE TO LAMINAR FLUID SHEAR STRESS 3 14 1.163e-05 0.0001431
379 POSITIVE REGULATION OF CELL CYCLE 8 332 1.175e-05 0.0001442
380 POSITIVE REGULATION OF GROWTH 7 238 1.198e-05 0.0001466
381 RESPONSE TO EXTRACELLULAR STIMULUS 9 441 1.216e-05 0.0001485
382 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 4 44 1.251e-05 0.0001524
383 REGULATION OF CELLULAR RESPONSE TO STRESS 11 691 1.265e-05 0.0001537
384 NEPHRON EPITHELIUM DEVELOPMENT 5 93 1.292e-05 0.0001566
385 REGULATION OF RESPONSE TO STRESS 16 1468 1.353e-05 0.0001635
386 REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS 5 94 1.362e-05 0.0001641
387 EXOCRINE SYSTEM DEVELOPMENT 4 45 1.369e-05 0.0001647
388 POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION 9 448 1.379e-05 0.0001653
389 REGULATION OF SECRETION 11 699 1.409e-05 0.0001685
390 NEGATIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 3 15 1.45e-05 0.0001725
391 VENOUS BLOOD VESSEL DEVELOPMENT 3 15 1.45e-05 0.0001725
392 POSITIVE REGULATION OF HEMOPOIESIS 6 163 1.484e-05 0.0001761
393 PEPTIDYL THREONINE MODIFICATION 4 46 1.496e-05 0.0001767
394 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 4 46 1.496e-05 0.0001767
395 HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION 5 98 1.668e-05 0.000196
396 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 5 98 1.668e-05 0.000196
397 EXTRINSIC APOPTOTIC SIGNALING PATHWAY 5 99 1.752e-05 0.0002054
398 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 4 48 1.775e-05 0.0002071
399 PARAXIAL MESODERM DEVELOPMENT 3 16 1.78e-05 0.0002071
400 ATRIOVENTRICULAR VALVE MORPHOGENESIS 3 16 1.78e-05 0.0002071
401 RESPONSE TO NITROGEN COMPOUND 12 859 1.801e-05 0.0002089
402 TAXIS 9 464 1.82e-05 0.0002107
403 CARDIAC SEPTUM MORPHOGENESIS 4 49 1.929e-05 0.0002227
404 POSITIVE REGULATION OF MAPK CASCADE 9 470 2.014e-05 0.0002307
405 WOUND HEALING 9 470 2.014e-05 0.0002307
406 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 9 470 2.014e-05 0.0002307
407 REGULATION OF ORGANELLE ORGANIZATION 14 1178 2.018e-05 0.0002307
408 GAMETE GENERATION 10 595 2.066e-05 0.0002356
409 REGULATION OF ADHERENS JUNCTION ORGANIZATION 4 50 2.091e-05 0.0002373
410 FACE DEVELOPMENT 4 50 2.091e-05 0.0002373
411 ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE 8 361 2.147e-05 0.000243
412 NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 3 17 2.157e-05 0.0002436
413 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 12 876 2.186e-05 0.0002463
414 REGULATION OF HORMONE SECRETION 7 262 2.226e-05 0.0002501
415 POSITIVE REGULATION OF PROTEOLYSIS 8 363 2.233e-05 0.0002504
416 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 8 365 2.323e-05 0.0002598
417 REGULATION OF FAT CELL DIFFERENTIATION 5 106 2.44e-05 0.0002709
418 CARDIAC VENTRICLE DEVELOPMENT 5 106 2.44e-05 0.0002709
419 FAT CELL DIFFERENTIATION 5 106 2.44e-05 0.0002709
420 PERICARDIUM DEVELOPMENT 3 18 2.582e-05 0.0002854
421 KIDNEY MESENCHYME DEVELOPMENT 3 18 2.582e-05 0.0002854
422 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 4 53 2.64e-05 0.000291
423 REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 5 108 2.67e-05 0.0002937
424 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 10 616 2.778e-05 0.0003049
425 REGULATION OF MYELOID CELL DIFFERENTIATION 6 183 2.854e-05 0.0003124
426 NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 4 55 3.059e-05 0.000331
427 REGULATION OF KIDNEY DEVELOPMENT 4 55 3.059e-05 0.000331
428 CELL CYCLE G1 S PHASE TRANSITION 5 111 3.047e-05 0.000331
429 G1 S TRANSITION OF MITOTIC CELL CYCLE 5 111 3.047e-05 0.000331
430 POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 3 19 3.059e-05 0.000331
431 REGULATION OF CELL CELL ADHESION 8 380 3.095e-05 0.0003342
432 REGULATION OF ENDOTHELIAL CELL MIGRATION 5 114 3.464e-05 0.0003723
433 NOTCH SIGNALING PATHWAY 5 114 3.464e-05 0.0003723
434 TRACHEA DEVELOPMENT 3 20 3.59e-05 0.000384
435 DORSAL VENTRAL AXIS SPECIFICATION 3 20 3.59e-05 0.000384
436 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 5 115 3.613e-05 0.0003856
437 REGULATION OF SYSTEM PROCESS 9 507 3.647e-05 0.0003883
438 REGULATION OF CELL GROWTH 8 391 3.789e-05 0.0004026
439 MAMMARY GLAND DEVELOPMENT 5 117 3.925e-05 0.000416
440 REGULATION OF DEVELOPMENTAL GROWTH 7 289 4.16e-05 0.0004399
441 CHONDROCYTE DEVELOPMENT 3 21 4.179e-05 0.0004409
442 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 6 197 4.312e-05 0.0004529
443 STEM CELL PROLIFERATION 4 60 4.321e-05 0.0004529
444 REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 4 60 4.321e-05 0.0004529
445 NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 6 200 4.691e-05 0.0004905
446 NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 3 22 4.828e-05 0.0005003
447 POSITIVE REGULATION OF TRANSLATIONAL INITIATION 3 22 4.828e-05 0.0005003
448 DSRNA FRAGMENTATION 3 22 4.828e-05 0.0005003
449 PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA 3 22 4.828e-05 0.0005003
450 SOMITOGENESIS 4 62 4.919e-05 0.0005087
451 PROTEIN TARGETING 8 406 4.942e-05 0.0005099
452 NEURON PROJECTION GUIDANCE 6 205 5.382e-05 0.000554
453 POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION 3 23 5.539e-05 0.0005652
454 PROSTATE GLAND MORPHOGENESIS 3 23 5.539e-05 0.0005652
455 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 3 23 5.539e-05 0.0005652
456 POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS 3 23 5.539e-05 0.0005652
457 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 7 303 5.61e-05 0.0005712
458 POSITIVE REGULATION OF BINDING 5 127 5.808e-05 0.0005901
459 GERM CELL DEVELOPMENT 6 209 5.992e-05 0.0006074
460 POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 3 24 6.316e-05 0.000632
461 POSITIVE REGULATION OF PROTEIN SECRETION 6 211 6.316e-05 0.000632
462 POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 3 24 6.316e-05 0.000632
463 NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION 3 24 6.316e-05 0.000632
464 REGULATION OF REPRODUCTIVE PROCESS 5 129 6.257e-05 0.000632
465 LENS DEVELOPMENT IN CAMERA TYPE EYE 4 66 6.294e-05 0.000632
466 REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 6 213 6.655e-05 0.0006645
467 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 4 67 6.677e-05 0.0006653
468 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 11 829 6.705e-05 0.0006657
469 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 10 684 6.71e-05 0.0006657
470 NEGATIVE REGULATION OF CELL CYCLE PROCESS 6 214 6.83e-05 0.0006761
471 REGULATION OF LYMPHOCYTE DIFFERENTIATION 5 132 6.979e-05 0.0006895
472 CELLULAR RESPONSE TO HORMONE STIMULUS 9 552 7.032e-05 0.0006932
473 CELL MOTILITY 11 835 7.152e-05 0.0007021
474 LOCALIZATION OF CELL 11 835 7.152e-05 0.0007021
475 RESPONSE TO DRUG 8 431 7.51e-05 0.0007357
476 MUSCLE STRUCTURE DEVELOPMENT 8 432 7.632e-05 0.0007451
477 REGULATION OF CELL CYCLE PROCESS 9 558 7.638e-05 0.0007451
478 CELL GROWTH 5 135 7.764e-05 0.0007558
479 NEGATIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 5 136 8.041e-05 0.0007811
480 MESODERMAL CELL DIFFERENTIATION 3 26 8.075e-05 0.0007828
481 REGULATION OF PROTEIN STABILITY 6 221 8.158e-05 0.0007891
482 CIRCADIAN RHYTHM 5 137 8.324e-05 0.0008019
483 ACTIVATION OF MAPK ACTIVITY 5 137 8.324e-05 0.0008019
484 RESPONSE TO DSRNA 4 72 8.854e-05 0.0008512
485 ERYTHROCYTE HOMEOSTASIS 4 73 9.345e-05 0.0008952
486 POSITIVE REGULATION OF ORGANELLE ORGANIZATION 9 573 9.35e-05 0.0008952
487 NEGATIVE REGULATION OF HORMONE SECRETION 4 74 9.855e-05 0.0009416
488 VENTRICULAR SEPTUM MORPHOGENESIS 3 28 0.0001013 0.0009637
489 POSITIVE REGULATION OF PHOSPHATASE ACTIVITY 3 28 0.0001013 0.0009637
490 BIOLOGICAL ADHESION 12 1032 0.0001067 0.001013
491 NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 3 29 0.0001127 0.001066
492 REGULATION OF OLIGODENDROCYTE DIFFERENTIATION 3 29 0.0001127 0.001066
493 SEXUAL REPRODUCTION 10 730 0.0001149 0.001081
494 REGULATION OF DNA METABOLIC PROCESS 7 340 0.0001153 0.001081
495 NEGATIVE REGULATION OF DEPHOSPHORYLATION 4 77 0.0001151 0.001081
496 REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 4 77 0.0001151 0.001081
497 POSITIVE REGULATION OF CELL GROWTH 5 148 0.0001198 0.001122
498 INTRACELLULAR SIGNAL TRANSDUCTION 15 1572 0.0001223 0.001142
499 SMOOTH MUSCLE CELL DIFFERENTIATION 3 30 0.0001249 0.001165
500 REGULATION OF MUSCLE CELL DIFFERENTIATION 5 152 0.0001358 0.001261
501 REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 5 152 0.0001358 0.001261
502 REGULATION OF MULTI ORGANISM PROCESS 8 470 0.0001367 0.001267
503 POSITIVE REGULATION OF CELL CELL ADHESION 6 243 0.0001372 0.001269
504 NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 4 82 0.0001469 0.001356
505 POSITIVE REGULATION OF MOLECULAR FUNCTION 16 1791 0.0001497 0.001379
506 POSITIVE REGULATION OF CELL CYCLE PROCESS 6 247 0.00015 0.001379
507 NUCLEAR TRANSPORT 7 355 0.0001505 0.001381
508 REGULATION OF ORGAN FORMATION 3 32 0.0001519 0.001386
509 PATTERNING OF BLOOD VESSELS 3 32 0.0001519 0.001386
510 BLOOD VESSEL REMODELING 3 32 0.0001519 0.001386
511 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 5 156 0.0001534 0.001397
512 PROTEOGLYCAN METABOLIC PROCESS 4 83 0.000154 0.001399
513 POSITIVE REGULATION OF MULTI ORGANISM PROCESS 5 157 0.000158 0.001433
514 EMBRYONIC AXIS SPECIFICATION 3 33 0.0001667 0.001506
515 REGULATION OF T CELL APOPTOTIC PROCESS 3 33 0.0001667 0.001506
516 POSITIVE REGULATION OF CELL CYCLE ARREST 4 85 0.0001688 0.001522
517 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 4 86 0.0001766 0.00159
518 CELL CYCLE PHASE TRANSITION 6 255 0.0001783 0.001602
519 RESPONSE TO FLUID SHEAR STRESS 3 34 0.0001824 0.001632
520 REGULATION OF PEPTIDE TRANSPORT 6 256 0.0001821 0.001632
521 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 7 368 0.0001877 0.001676
522 POSITIVE REGULATION OF CYTOKINE PRODUCTION 7 370 0.000194 0.001729
523 POST EMBRYONIC DEVELOPMENT 4 89 0.0002016 0.001794
524 NEGATIVE REGULATION OF LOCOMOTION 6 263 0.0002107 0.001864
525 REGULATION OF CELL MATRIX ADHESION 4 90 0.0002105 0.001864
526 ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE 4 90 0.0002105 0.001864
527 REGULATION OF ERYTHROCYTE DIFFERENTIATION 3 36 0.0002167 0.001906
528 CORTICAL CYTOSKELETON ORGANIZATION 3 36 0.0002167 0.001906
529 HEAD MORPHOGENESIS 3 36 0.0002167 0.001906
530 CELLULAR RESPONSE TO NITROGEN COMPOUND 8 505 0.0002231 0.001958
531 NEGATIVE REGULATION OF CELL GROWTH 5 170 0.0002289 0.002005
532 HINDLIMB MORPHOGENESIS 3 37 0.0002352 0.002054
533 REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 3 37 0.0002352 0.002054
534 REGULATION OF DNA BINDING 4 93 0.0002388 0.002081
535 REGULATION OF CELL DIVISION 6 272 0.0002525 0.002196
536 RESPONSE TO TESTOSTERONE 3 38 0.0002548 0.002204
537 CELLULAR RESPONSE TO DSRNA 3 38 0.0002548 0.002204
538 REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 3 38 0.0002548 0.002204
539 HOMEOSTASIS OF NUMBER OF CELLS 5 175 0.0002617 0.002259
540 RESPONSE TO CORTICOSTEROID 5 176 0.0002687 0.002315
541 ANATOMICAL STRUCTURE MATURATION 3 39 0.0002754 0.002369
542 MUSCLE ORGAN DEVELOPMENT 6 277 0.0002785 0.00239
543 NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 4 98 0.0002918 0.002501
544 NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION 3 40 0.0002971 0.002541
545 POSITIVE REGULATION OF CATALYTIC ACTIVITY 14 1518 0.0003061 0.002611
546 REGULATION OF LIPID METABOLIC PROCESS 6 282 0.0003064 0.002611
547 NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 3 41 0.0003198 0.002705
548 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 3 41 0.0003198 0.002705
549 PROSTATE GLAND DEVELOPMENT 3 41 0.0003198 0.002705
550 LUNG ALVEOLUS DEVELOPMENT 3 41 0.0003198 0.002705
551 NEURON PROJECTION MORPHOGENESIS 7 402 0.0003211 0.002712
552 REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 4 101 0.0003275 0.00276
553 POSITIVE REGULATION OF DNA METABOLIC PROCESS 5 185 0.0003381 0.002845
554 POSTTRANSCRIPTIONAL GENE SILENCING 3 42 0.0003436 0.00288
555 EPITHELIAL CELL MORPHOGENESIS 3 42 0.0003436 0.00288
556 APOPTOTIC SIGNALING PATHWAY 6 289 0.0003492 0.002923
557 CARDIAC CHAMBER MORPHOGENESIS 4 104 0.0003661 0.003058
558 NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION 3 43 0.0003685 0.003066
559 LEUKOCYTE DIFFERENTIATION 6 292 0.0003689 0.003066
560 BETA CATENIN TCF COMPLEX ASSEMBLY 3 43 0.0003685 0.003066
561 RESPONSE TO NUTRIENT 5 191 0.0003914 0.003246
562 BODY MORPHOGENESIS 3 44 0.0003945 0.003266
563 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 6 296 0.0003966 0.003278
564 PLATELET DEGRANULATION 4 107 0.0004079 0.003365
565 NEGATIVE REGULATION OF PROTEIN SECRETION 4 108 0.0004226 0.003462
566 REGULATION OF EPIDERMAL CELL DIFFERENTIATION 3 45 0.0004217 0.003462
567 REGULATION OF CELL CYCLE ARREST 4 108 0.0004226 0.003462
568 REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 3 45 0.0004217 0.003462
569 EAR DEVELOPMENT 5 195 0.0004303 0.003519
570 REGULATION OF CELL PROJECTION ORGANIZATION 8 558 0.0004354 0.003554
571 REGULATION OF PROTEOLYSIS 9 711 0.0004643 0.003784
572 RESPONSE TO ANTIBIOTIC 3 47 0.0004797 0.003888
573 RESPONSE TO CYTOKINE 9 714 0.0004787 0.003888
574 POSITIVE REGULATION OF DEPHOSPHORYLATION 3 47 0.0004797 0.003888
575 NEGATIVE REGULATION OF SECRETION 5 200 0.000483 0.003908
576 CELL ACTIVATION 8 568 0.0004896 0.003955
577 REGULATION OF MYOBLAST DIFFERENTIATION 3 48 0.0005105 0.004109
578 REGULATION OF ENDOCRINE PROCESS 3 48 0.0005105 0.004109
579 REGULATION OF ACTIN FILAMENT BASED PROCESS 6 312 0.0005238 0.004209
580 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 9 724 0.0005292 0.004246
581 NEGATIVE REGULATION OF PEPTIDE SECRETION 3 49 0.0005425 0.004337
582 REGULATION OF STEROID BIOSYNTHETIC PROCESS 3 49 0.0005425 0.004337
583 ENDOCARDIUM DEVELOPMENT 2 11 0.0005613 0.004457
584 REGULATION OF REMOVAL OF SUPEROXIDE RADICALS 2 11 0.0005613 0.004457
585 LYMPHANGIOGENESIS 2 11 0.0005613 0.004457
586 REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH 2 11 0.0005613 0.004457
587 POSITIVE REGULATION OF MAP KINASE ACTIVITY 5 207 0.0005647 0.004476
588 RESPONSE TO PROGESTERONE 3 50 0.0005758 0.004541
589 ENDODERM FORMATION 3 50 0.0005758 0.004541
590 POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 3 50 0.0005758 0.004541
591 NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 5 209 0.0005899 0.004636
592 REGULATION OF PEPTIDE SECRETION 5 209 0.0005899 0.004636
593 SINGLE ORGANISM CELLULAR LOCALIZATION 10 898 0.0006015 0.00472
594 RESPONSE TO MECHANICAL STIMULUS 5 210 0.0006027 0.004721
595 REGULATION OF CELL CYCLE PHASE TRANSITION 6 321 0.0006081 0.004755
596 ARTERY MORPHOGENESIS 3 51 0.0006104 0.004765
597 POSITIVE REGULATION OF CHEMOTAXIS 4 120 0.0006292 0.004904
598 POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION 2 12 0.0006722 0.005153
599 NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH 2 12 0.0006722 0.005153
600 REGULATION OF VITAMIN METABOLIC PROCESS 2 12 0.0006722 0.005153
601 REGULATION OF MACROPHAGE CYTOKINE PRODUCTION 2 12 0.0006722 0.005153
602 HEART FORMATION 2 12 0.0006722 0.005153
603 REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS 2 12 0.0006722 0.005153
604 MAMMARY GLAND EPITHELIAL CELL PROLIFERATION 2 12 0.0006722 0.005153
605 GROWTH PLATE CARTILAGE DEVELOPMENT 2 12 0.0006722 0.005153
606 NEGATIVE REGULATION OF HEART GROWTH 2 12 0.0006722 0.005153
607 POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION 2 12 0.0006722 0.005153
608 NEGATIVE REGULATION OF TRANSPORT 7 458 0.0006985 0.005346
609 CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 5 218 0.0007136 0.005452
610 NEGATIVE REGULATION OF REPRODUCTIVE PROCESS 3 54 0.000722 0.005489
611 REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS 3 54 0.000722 0.005489
612 CARDIAC MUSCLE TISSUE MORPHOGENESIS 3 54 0.000722 0.005489
613 NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION 2 13 0.0007927 0.00594
614 POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS 2 13 0.0007927 0.00594
615 MITOTIC CELL CYCLE 9 766 0.000792 0.00594
616 BEHAVIORAL RESPONSE TO PAIN 2 13 0.0007927 0.00594
617 LEUKOCYTE TETHERING OR ROLLING 2 13 0.0007927 0.00594
618 LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL 2 13 0.0007927 0.00594
619 LYMPH VESSEL MORPHOGENESIS 2 13 0.0007927 0.00594
620 TELENCEPHALON REGIONALIZATION 2 13 0.0007927 0.00594
621 MESODERMAL CELL FATE COMMITMENT 2 13 0.0007927 0.00594
622 NEGATIVE REGULATION OF HEMOPOIESIS 4 128 0.0008014 0.005995
623 REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 3 57 0.0008458 0.006317
624 POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 4 131 0.0008738 0.006484
625 NEGATIVE REGULATION OF BINDING 4 131 0.0008738 0.006484
626 RETINA DEVELOPMENT IN CAMERA TYPE EYE 4 131 0.0008738 0.006484
627 TELENCEPHALON DEVELOPMENT 5 228 0.0008728 0.006484
628 PROTEOGLYCAN BIOSYNTHETIC PROCESS 3 58 0.0008898 0.006583
629 POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS 3 58 0.0008898 0.006583
630 MAINTENANCE OF CELL NUMBER 4 132 0.0008989 0.006639
631 POSITIVE REGULATION OF P38MAPK CASCADE 2 14 0.0009229 0.006763
632 METANEPHRIC MESENCHYME DEVELOPMENT 2 14 0.0009229 0.006763
633 CRANIOFACIAL SUTURE MORPHOGENESIS 2 14 0.0009229 0.006763
634 ADENOHYPOPHYSIS DEVELOPMENT 2 14 0.0009229 0.006763
635 BONE MATURATION 2 14 0.0009229 0.006763
636 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 5 232 0.0009434 0.006902
637 RESPONSE TO ENDOPLASMIC RETICULUM STRESS 5 233 0.0009617 0.007025
638 REGULATION OF CELL ACTIVATION 7 484 0.0009648 0.007037
639 PROTEIN COMPLEX BIOGENESIS 11 1132 0.0009732 0.007075
640 PROTEIN COMPLEX ASSEMBLY 11 1132 0.0009732 0.007075
641 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 4 135 0.0009773 0.007095
642 NEGATIVE REGULATION OF CELL DIVISION 3 60 0.0009823 0.007108
643 REGULATION OF MONOOXYGENASE ACTIVITY 3 60 0.0009823 0.007108
644 SECRETION BY CELL 7 486 0.0009882 0.00714
645 REGULATION OF HYDROLASE ACTIVITY 12 1327 0.001048 0.007559
646 N TERMINAL PROTEIN AMINO ACID ACETYLATION 2 15 0.001063 0.007572
647 ENDOCARDIAL CUSHION FORMATION 2 15 0.001063 0.007572
648 REGULATION OF MESODERM DEVELOPMENT 2 15 0.001063 0.007572
649 REGULATION OF CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS 2 15 0.001063 0.007572
650 STRIATED MUSCLE CELL PROLIFERATION 2 15 0.001063 0.007572
651 CHRONIC INFLAMMATORY RESPONSE 2 15 0.001063 0.007572
652 POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS 2 15 0.001063 0.007572
653 POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS 2 15 0.001063 0.007572
654 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 9 799 0.001066 0.007586
655 SENSORY ORGAN MORPHOGENESIS 5 239 0.001077 0.007652
656 MITOTIC CELL CYCLE CHECKPOINT 4 139 0.001089 0.007726
657 PROTEIN COMPLEX SUBUNIT ORGANIZATION 13 1527 0.001102 0.007802
658 RESPONSE TO TOXIC SUBSTANCE 5 241 0.001118 0.007904
659 REGULATION OF CYTOSKELETON ORGANIZATION 7 502 0.001192 0.008417
660 MODULATION OF GROWTH OF SYMBIONT INVOLVED IN INTERACTION WITH HOST 2 16 0.001212 0.008493
661 REGULATION OF MONONUCLEAR CELL MIGRATION 2 16 0.001212 0.008493
662 ORGAN INDUCTION 2 16 0.001212 0.008493
663 POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION 2 16 0.001212 0.008493
664 RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE 2 16 0.001212 0.008493
665 SOMATIC STEM CELL POPULATION MAINTENANCE 3 66 0.001295 0.009051
666 CELLULAR RESPONSE TO UV 3 66 0.001295 0.009051
667 NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION 4 146 0.001306 0.009113
668 NEGATIVE REGULATION OF KIDNEY DEVELOPMENT 2 17 0.001371 0.009505
669 EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS 2 17 0.001371 0.009505
670 POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION 2 17 0.001371 0.009505
671 POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 2 17 0.001371 0.009505
672 PEPTIDYL SERINE MODIFICATION 4 148 0.001373 0.00951
673 MULTICELLULAR ORGANISMAL RESPONSE TO STRESS 3 68 0.001412 0.009764
674 LEUKOCYTE CELL CELL ADHESION 5 255 0.001435 0.009907
NumGOOverlapSizeP ValueAdj. P Value
1 TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING 18 50 2.061e-33 1.914e-30
2 RECEPTOR SIGNALING PROTEIN ACTIVITY 19 172 1.802e-24 8.37e-22
3 SMAD BINDING 15 72 8.407e-24 2.603e-21
4 CYTOKINE RECEPTOR BINDING 20 271 3.531e-22 8.201e-20
5 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY 10 17 1.215e-21 2.258e-19
6 I SMAD BINDING 7 11 8.964e-16 1.388e-13
7 GROWTH FACTOR ACTIVITY 13 160 3.846e-15 5.104e-13
8 RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY 11 92 7.69e-15 8.931e-13
9 CYTOKINE ACTIVITY 14 219 8.744e-15 9.025e-13
10 RECEPTOR SERINE THREONINE KINASE BINDING 7 15 1.73e-14 1.607e-12
11 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 10 81 9.996e-14 8.442e-12
12 PROTEIN SERINE THREONINE KINASE ACTIVITY 16 445 6.591e-13 5.102e-11
13 ACTIVIN BINDING 6 12 8.463e-13 6.048e-11
14 TRANSFORMING GROWTH FACTOR BETA BINDING 6 16 7.261e-12 4.497e-10
15 GROWTH FACTOR BINDING 10 123 7.185e-12 4.497e-10
16 RECEPTOR BINDING 24 1476 1.178e-11 6.839e-10
17 CYTOKINE BINDING 9 92 1.599e-11 8.737e-10
18 PROTEIN DIMERIZATION ACTIVITY 21 1149 3.948e-11 2.038e-09
19 TRANSCRIPTION FACTOR BINDING 15 524 9.586e-11 4.687e-09
20 IDENTICAL PROTEIN BINDING 21 1209 1.016e-10 4.72e-09
21 PROTEIN KINASE ACTIVITY 16 640 1.516e-10 6.707e-09
22 KINASE ACTIVITY 16 842 7.911e-09 3.34e-07
23 R SMAD BINDING 5 23 9.968e-09 4.026e-07
24 SIGNAL TRANSDUCER ACTIVITY 22 1731 1.153e-08 4.462e-07
25 GLYCOSAMINOGLYCAN BINDING 9 205 2.039e-08 7.576e-07
26 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 18 1199 2.97e-08 1.061e-06
27 RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 7 104 4.556e-08 1.567e-06
28 CO SMAD BINDING 4 12 4.931e-08 1.636e-06
29 MACROMOLECULAR COMPLEX BINDING 19 1399 5.507e-08 1.764e-06
30 PROTEIN HOMODIMERIZATION ACTIVITY 14 722 6.234e-08 1.931e-06
31 COLLAGEN BINDING 6 65 6.615e-08 1.982e-06
32 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 16 992 7.781e-08 2.259e-06
33 PROTEIN COMPLEX BINDING 15 935 2.303e-07 6.482e-06
34 CORE PROMOTER PROXIMAL REGION DNA BINDING 10 371 3.089e-07 8.441e-06
35 HEPARIN BINDING 7 157 7.634e-07 2.026e-05
36 SULFUR COMPOUND BINDING 8 234 8.856e-07 2.285e-05
37 ACTIVATING TRANSCRIPTION FACTOR BINDING 5 57 1.139e-06 2.861e-05
38 REGULATORY REGION NUCLEIC ACID BINDING 13 818 1.866e-06 4.561e-05
39 BHLH TRANSCRIPTION FACTOR BINDING 4 28 1.962e-06 4.673e-05
40 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 11 629 5.219e-06 0.0001212
41 RNA POLYMERASE II ACTIVATING TRANSCRIPTION FACTOR BINDING 4 36 5.534e-06 0.0001254
42 DOUBLE STRANDED DNA BINDING 11 764 3.201e-05 0.000708
43 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 7 328 9.219e-05 0.001992
44 PROTEIN HETERODIMERIZATION ACTIVITY 8 468 0.0001328 0.002803
45 ADENYL NUCLEOTIDE BINDING 14 1514 0.000298 0.006151
46 GLYCOPROTEIN BINDING 4 101 0.0003275 0.006473
47 CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING 4 101 0.0003275 0.006473
48 ENZYME BINDING 15 1737 0.0003647 0.007059
49 SEQUENCE SPECIFIC DNA BINDING 11 1037 0.0004704 0.008919
50 CHROMATIN BINDING 7 435 0.0005151 0.00957
NumGOOverlapSizeP ValueAdj. P Value
1 TRANSCRIPTION FACTOR COMPLEX 15 298 2.959e-14 1.728e-11
2 EXTRACELLULAR SPACE 20 1376 7.012e-09 2.048e-06
3 RECEPTOR COMPLEX 10 327 9.607e-08 1.87e-05
4 EXTRACELLULAR MATRIX 10 426 1.088e-06 0.0001589
5 PLASMA MEMBRANE RECEPTOR COMPLEX 7 175 1.581e-06 0.0001847
6 PLATELET ALPHA GRANULE 5 75 4.49e-06 0.0004213
7 CELL SURFACE 12 757 5.05e-06 0.0004213
8 PLATELET ALPHA GRANULE LUMEN 4 55 3.059e-05 0.002233
9 MEMBRANE MICRODOMAIN 7 288 4.07e-05 0.002377
10 PLASMA MEMBRANE PROTEIN COMPLEX 9 510 3.818e-05 0.002377
11 EXTERNAL SIDE OF PLASMA MEMBRANE 6 238 0.0001225 0.006504
12 SECRETORY GRANULE LUMEN 4 85 0.0001688 0.007935
13 PLASMA MEMBRANE RAFT 4 86 0.0001766 0.007935
14 PROTEIN KINASE COMPLEX 4 90 0.0002105 0.008781

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04350_TGF.beta_signaling_pathway 64 85 2.147e-165 3.865e-163
2 hsa04390_Hippo_signaling_pathway 23 154 7.671e-33 6.904e-31
3 hsa04110_Cell_cycle 13 128 2.008e-16 1.205e-14
4 hsa04144_Endocytosis 11 203 4.979e-11 2.013e-09
5 hsa04310_Wnt_signaling_pathway 10 151 5.591e-11 2.013e-09
6 hsa04520_Adherens_junction 8 73 9.073e-11 2.722e-09
7 hsa04151_PI3K_AKT_signaling_pathway 11 351 1.598e-08 4.108e-07
8 hsa04340_Hedgehog_signaling_pathway 5 56 1.042e-06 2.344e-05
9 hsa04380_Osteoclast_differentiation 6 128 3.704e-06 6.907e-05
10 hsa04510_Focal_adhesion 7 200 3.837e-06 6.907e-05
11 hsa04010_MAPK_signaling_pathway 7 268 2.573e-05 0.000421
12 hsa04512_ECM.receptor_interaction 4 85 0.0001688 0.002533
13 hsa04012_ErbB_signaling_pathway 4 87 0.0001847 0.002558
14 hsa04150_mTOR_signaling_pathway 3 52 0.0006462 0.008309
15 hsa04720_Long.term_potentiation 3 70 0.001535 0.01666
16 hsa04730_Long.term_depression 3 70 0.001535 0.01666
17 hsa04630_Jak.STAT_signaling_pathway 4 155 0.001628 0.01666
18 hsa04145_Phagosome 4 156 0.001666 0.01666
19 hsa04666_Fc_gamma_R.mediated_phagocytosis 3 95 0.003665 0.03472
20 hsa04916_Melanogenesis 3 101 0.004352 0.03917
21 hsa04660_T_cell_receptor_signaling_pathway 3 108 0.005246 0.04497
22 hsa04114_Oocyte_meiosis 3 114 0.006095 0.04987
23 hsa04270_Vascular_smooth_muscle_contraction 3 116 0.006395 0.05005
24 hsa04360_Axon_guidance 3 130 0.008741 0.06556
25 hsa04650_Natural_killer_cell_mediated_cytotoxicity 3 136 0.009882 0.06854
26 hsa04330_Notch_signaling_pathway 2 47 0.01023 0.06854
27 hsa04910_Insulin_signaling_pathway 3 138 0.01028 0.06854
28 hsa04621_NOD.like_receptor_signaling_pathway 2 59 0.0158 0.1016
29 hsa04062_Chemokine_signaling_pathway 3 189 0.02365 0.1468
30 hsa04612_Antigen_processing_and_presentation 2 78 0.02666 0.1585
31 hsa04664_Fc_epsilon_RI_signaling_pathway 2 79 0.02729 0.1585
32 hsa03015_mRNA_surveillance_pathway 2 83 0.0299 0.1682
33 hsa04810_Regulation_of_actin_cytoskeleton 3 214 0.03249 0.1772
34 hsa04620_Toll.like_receptor_signaling_pathway 2 102 0.04352 0.2304
35 hsa04670_Leukocyte_transendothelial_migration 2 117 0.0556 0.2859
36 hsa04530_Tight_junction 2 133 0.06961 0.348

lncRNA-mediated sponge

(Download full result)

Num lncRNA miRNAs           miRNAs count     Gene Sponge regulatory network lncRNA log2FC lncRNA pvalue Gene log2FC Gene pvalue lncRNA-gene Pearson correlation
1

MAGI2-AS3

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-142-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-93-5p 13 THBS2 Sponge network -4.563 0 -2.628 0.00636 0.694
2

MAGI2-AS3

hsa-let-7d-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-3065-5p;hsa-miR-32-5p;hsa-miR-33a-3p;hsa-miR-500a-5p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-616-5p;hsa-miR-92a-3p 18 THBS1 Sponge network -4.563 0 -3.751 0.0001 0.664
3

RP11-166D19.1

hsa-let-7d-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-32-5p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-616-5p;hsa-miR-92a-3p 16 THBS1 Sponge network -4.209 2.0E-5 -3.751 0.0001 0.639
4

MIR143HG

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-142-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p 12 THBS2 Sponge network -6.51 0 -2.628 0.00636 0.606
5

MIR143HG

hsa-let-7d-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-3065-5p;hsa-miR-32-5p;hsa-miR-33a-3p;hsa-miR-500a-5p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-616-5p;hsa-miR-92a-3p 18 THBS1 Sponge network -6.51 0 -3.751 0.0001 0.603
6

DNM3OS

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-142-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-32-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p;hsa-miR-96-5p 13 THBS2 Sponge network -3.933 0.00059 -2.628 0.00636 0.597
7

MEG3

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-3614-5p;hsa-miR-590-5p;hsa-miR-93-5p;hsa-miR-96-5p 11 THBS2 Sponge network -3.613 0.00075 -2.628 0.00636 0.586
8

RP11-166D19.1

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-142-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-32-3p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-96-5p 13 THBS2 Sponge network -4.209 2.0E-5 -2.628 0.00636 0.584
9

DNM3OS

hsa-let-7d-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-3065-5p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-616-5p 15 THBS1 Sponge network -3.933 0.00059 -3.751 0.0001 0.584
10

NR2F2-AS1

hsa-miR-106b-5p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-590-3p;hsa-miR-9-3p;hsa-miR-92a-3p;hsa-miR-93-5p 12 TGFBR2 Sponge network -3.785 0.00281 -2.733 2.0E-5 0.556
11

MEG3

hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-616-5p 14 THBS1 Sponge network -3.613 0.00075 -3.751 0.0001 0.544
12

RP11-344E13.3

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-142-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-29b-3p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p 12 THBS2 Sponge network -4.307 3.0E-5 -2.628 0.00636 0.485
13

MAGI2-AS3

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-454-3p;hsa-miR-502-5p;hsa-miR-590-3p;hsa-miR-9-3p;hsa-miR-92a-3p;hsa-miR-93-5p 17 TGFBR2 Sponge network -4.563 0 -2.733 2.0E-5 0.479
14

TPTEP1

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-142-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-335-3p;hsa-miR-3614-5p;hsa-miR-590-3p 10 THBS2 Sponge network -4.398 5.0E-5 -2.628 0.00636 0.465
15

LINC00284

hsa-miR-106b-5p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p 10 TGFBR2 Sponge network -5.478 0.02716 -2.733 2.0E-5 0.434
16

RP11-166D19.1

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-454-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-9-5p;hsa-miR-92a-3p 16 TGFBR2 Sponge network -4.209 2.0E-5 -2.733 2.0E-5 0.422
17 CTD-2334D19.1 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-454-3p;hsa-miR-590-3p;hsa-miR-93-5p 10 TGFBR2 Sponge network -4.489 0.03789 -2.733 2.0E-5 0.419
18

EMX2OS

hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-33a-3p;hsa-miR-454-3p;hsa-miR-590-3p;hsa-miR-92a-3p;hsa-miR-93-5p 13 TGFBR2 Sponge network -6.205 0.00015 -2.733 2.0E-5 0.417
19

HAND2-AS1

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-93-5p 11 THBS2 Sponge network -7.871 0 -2.628 0.00636 0.398
20

HAND2-AS1

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-92a-3p;hsa-miR-93-5p 14 TGFBR2 Sponge network -7.871 0 -2.733 2.0E-5 0.394
21

ACTA2-AS1

hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-590-3p;hsa-miR-93-3p 12 BMPR2 Sponge network -6.142 0.00223 -1.126 0.00109 0.39
22

RP11-166D19.1

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200b-3p;hsa-miR-25-3p;hsa-miR-32-5p;hsa-miR-363-3p;hsa-miR-590-3p;hsa-miR-96-5p 10 SMAD7 Sponge network -4.209 2.0E-5 -0.959 0.0367 0.387
23

DNM3OS

hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-3p;hsa-miR-93-5p 12 BMPR2 Sponge network -3.933 0.00059 -1.126 0.00109 0.382
24

MAGI2-AS3

hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-30b-5p;hsa-miR-30e-5p;hsa-miR-32-5p;hsa-miR-590-3p;hsa-miR-92a-3p;hsa-miR-93-3p;hsa-miR-93-5p 17 BMPR2 Sponge network -4.563 0 -1.126 0.00109 0.376
25

TPTEP1

hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-32-5p;hsa-miR-590-3p;hsa-miR-92a-3p 10 THBS1 Sponge network -4.398 5.0E-5 -3.751 0.0001 0.373
26

HAND2-AS1

hsa-let-7d-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-32-5p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-616-5p;hsa-miR-92a-3p 15 THBS1 Sponge network -7.871 0 -3.751 0.0001 0.372
27 LINC00473 hsa-miR-106a-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-23b-3p;hsa-miR-33a-3p;hsa-miR-590-3p;hsa-miR-9-3p;hsa-miR-9-5p;hsa-miR-92a-3p 10 TGFBR2 Sponge network -6.247 0.02928 -2.733 2.0E-5 0.371
28

ACTA2-AS1

hsa-let-7d-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-590-3p 13 THBS1 Sponge network -6.142 0.00223 -3.751 0.0001 0.37
29

RP11-389C8.2

hsa-let-7b-5p;hsa-let-7d-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-3065-5p;hsa-miR-33a-3p 12 THBS1 Sponge network -3.089 2.0E-5 -3.751 0.0001 0.369
30

DNM3OS

hsa-let-7f-1-3p;hsa-miR-142-5p;hsa-miR-155-5p;hsa-miR-27a-3p;hsa-miR-3065-5p;hsa-miR-320c;hsa-miR-330-3p;hsa-miR-590-3p;hsa-miR-625-3p;hsa-miR-629-3p 10 SMAD9 Sponge network -3.933 0.00059 -2.738 0.0193 0.368
31

MAGI2-AS3

hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-142-5p;hsa-miR-155-5p;hsa-miR-2355-5p;hsa-miR-27a-3p;hsa-miR-3065-5p;hsa-miR-452-3p;hsa-miR-590-3p;hsa-miR-625-3p;hsa-miR-629-3p 11 SMAD9 Sponge network -4.563 0 -2.738 0.0193 0.367
32

RP11-567M16.1

hsa-miR-106b-5p;hsa-miR-146b-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-29b-3p;hsa-miR-335-3p;hsa-miR-3614-5p;hsa-miR-590-5p;hsa-miR-93-5p 10 THBS2 Sponge network -2.638 0.21408 -2.628 0.00636 0.363
33

MIR143HG

hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-200b-3p;hsa-miR-224-3p;hsa-miR-3065-5p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-30d-5p;hsa-miR-30e-5p;hsa-miR-3607-3p 10 INHBA Sponge network -6.51 0 0.597 0.64331 0.362
34

ADAMTS9-AS1

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-142-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-335-3p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p;hsa-miR-96-5p 14 THBS2 Sponge network -8.573 0.00012 -2.628 0.00636 0.355
35

MIR143HG

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-92a-3p;hsa-miR-93-5p 14 TGFBR2 Sponge network -6.51 0 -2.733 2.0E-5 0.353
36

WT1-AS

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-142-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-590-3p;hsa-miR-93-5p;hsa-miR-96-5p 12 THBS2 Sponge network -6.875 2.0E-5 -2.628 0.00636 0.351
37

RP11-344E13.3

hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-30e-5p;hsa-miR-32-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-3p;hsa-miR-93-5p 13 BMPR2 Sponge network -4.307 3.0E-5 -1.126 0.00109 0.34
38 NR2F1-AS1 hsa-let-7f-1-3p;hsa-miR-146b-3p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-32-5p;hsa-miR-590-3p;hsa-miR-92a-3p 11 BMPR2 Sponge network -2.961 0.00154 -1.126 0.00109 0.336
39

DNM3OS

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-454-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p 15 TGFBR2 Sponge network -3.933 0.00059 -2.733 2.0E-5 0.336
40 RP11-1036E20.9 hsa-miR-106b-5p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-502-5p;hsa-miR-92a-3p;hsa-miR-93-5p 10 TGFBR2 Sponge network -0.331 0.90522 -2.733 2.0E-5 0.335
41 SNHG14 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-142-5p;hsa-miR-155-5p;hsa-miR-27a-3p;hsa-miR-3065-5p;hsa-miR-320c;hsa-miR-330-3p;hsa-miR-452-3p;hsa-miR-629-3p 10 SMAD9 Sponge network -3.108 0.00332 -2.738 0.0193 0.334
42

MIR143HG

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200b-3p;hsa-miR-25-3p;hsa-miR-32-5p;hsa-miR-34a-5p;hsa-miR-363-3p;hsa-miR-590-3p;hsa-miR-93-5p 11 SMAD7 Sponge network -6.51 0 -0.959 0.0367 0.333
43

MAGI2-AS3

hsa-miR-107;hsa-miR-142-3p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-197-3p;hsa-miR-19b-3p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-30e-5p;hsa-miR-362-3p;hsa-miR-454-3p;hsa-miR-590-3p 13 ACVR1 Sponge network -4.563 0 -0.765 0.04389 0.332
44 RP11-819C21.1 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-30b-5p;hsa-miR-590-3p;hsa-miR-93-5p 11 BMPR2 Sponge network -1.571 0.00379 -1.126 0.00109 0.331
45 SOCS2-AS1 hsa-let-7d-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-33a-3p;hsa-miR-590-3p;hsa-miR-616-5p 10 THBS1 Sponge network -4.167 1.0E-5 -3.751 0.0001 0.33
46

MEG3

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-454-3p;hsa-miR-590-5p;hsa-miR-93-5p 14 TGFBR2 Sponge network -3.613 0.00075 -2.733 2.0E-5 0.325
47

RP11-344E13.3

hsa-miR-107;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-30c-5p;hsa-miR-30d-5p;hsa-miR-30e-5p;hsa-miR-338-3p;hsa-miR-454-3p;hsa-miR-590-3p 10 ACVR1 Sponge network -4.307 3.0E-5 -0.765 0.04389 0.325
48 WDR86-AS1 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-9-3p 10 TGFBR2 Sponge network -2.587 0.08454 -2.733 2.0E-5 0.325
49

AC003090.1

hsa-miR-106b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p;hsa-miR-96-5p 10 THBS2 Sponge network -7.817 0.00161 -2.628 0.00636 0.321
50

RP11-166D19.1

hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-32-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-92a-3p;hsa-miR-93-3p 15 BMPR2 Sponge network -4.209 2.0E-5 -1.126 0.00109 0.321
51

HAND2-AS1

hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-30b-5p;hsa-miR-32-5p;hsa-miR-590-3p;hsa-miR-92a-3p;hsa-miR-93-3p;hsa-miR-93-5p 16 BMPR2 Sponge network -7.871 0 -1.126 0.00109 0.317
52

TRHDE-AS1

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-142-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p 13 THBS2 Sponge network -6.205 0.01165 -2.628 0.00636 0.315
53

ACTA2-AS1

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-142-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-29b-3p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-96-5p 12 THBS2 Sponge network -6.142 0.00223 -2.628 0.00636 0.313
54

ACTA2-AS1

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-33a-3p;hsa-miR-454-3p;hsa-miR-590-3p 12 TGFBR2 Sponge network -6.142 0.00223 -2.733 2.0E-5 0.31
55 IGF2-AS hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-146b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-93-3p;hsa-miR-93-5p 10 BMPR2 Sponge network -7.051 0.01788 -1.126 0.00109 0.31
56

RP11-130L8.1

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p 11 TGFBR2 Sponge network -4.329 1.0E-5 -2.733 2.0E-5 0.307
57

MAGI2-AS3

hsa-miR-141-3p;hsa-miR-142-3p;hsa-miR-148b-3p;hsa-miR-200a-3p;hsa-miR-2277-5p;hsa-miR-362-3p;hsa-miR-362-5p;hsa-miR-429;hsa-miR-454-3p;hsa-miR-500a-5p;hsa-miR-500b-5p;hsa-miR-616-5p;hsa-miR-9-3p 13 TGFB2 Sponge network -4.563 0 -1.437 0.20815 0.306
58

RP11-116O18.1

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p 12 TGFBR2 Sponge network -5.007 0.06008 -2.733 2.0E-5 0.306
59

MAGI2-AS3

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200b-3p;hsa-miR-25-3p;hsa-miR-32-5p;hsa-miR-363-3p;hsa-miR-590-3p;hsa-miR-93-5p 10 SMAD7 Sponge network -4.563 0 -0.959 0.0367 0.304
60

RP11-116O18.1

hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p 13 BMPR2 Sponge network -5.007 0.06008 -1.126 0.00109 0.302
61

LINC00284

hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-142-5p;hsa-miR-155-5p;hsa-miR-2355-5p;hsa-miR-27a-3p;hsa-miR-330-3p;hsa-miR-3682-3p;hsa-miR-452-3p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-944 12 SMAD9 Sponge network -5.478 0.02716 -2.738 0.0193 0.299
62 PWAR6 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-142-5p;hsa-miR-155-5p;hsa-miR-2355-5p;hsa-miR-27a-3p;hsa-miR-320c;hsa-miR-330-3p;hsa-miR-629-3p;hsa-miR-944 10 SMAD9 Sponge network -3.15 0.0082 -2.738 0.0193 0.298
63 LINC00865 hsa-let-7d-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-500a-5p;hsa-miR-616-5p 12 THBS1 Sponge network -1.585 0.19508 -3.751 0.0001 0.29
64

RP11-567M16.1

hsa-let-7d-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-616-5p 10 THBS1 Sponge network -2.638 0.21408 -3.751 0.0001 0.29
65

EMX2OS

hsa-miR-106b-5p;hsa-miR-142-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-93-5p 10 THBS2 Sponge network -6.205 0.00015 -2.628 0.00636 0.29
66

MEG3

hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-590-5p;hsa-miR-93-3p;hsa-miR-93-5p 12 BMPR2 Sponge network -3.613 0.00075 -1.126 0.00109 0.29
67

HAND2-AS1

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200b-3p;hsa-miR-25-3p;hsa-miR-32-5p;hsa-miR-34a-5p;hsa-miR-363-3p;hsa-miR-590-3p;hsa-miR-93-5p 11 SMAD7 Sponge network -7.871 0 -0.959 0.0367 0.289
68 ZNF667-AS1 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-590-5p;hsa-miR-93-5p 11 BMPR2 Sponge network -4.019 0.00137 -1.126 0.00109 0.288
69 RP11-822E23.8 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-93-3p;hsa-miR-93-5p 12 BMPR2 Sponge network -8.351 0.00374 -1.126 0.00109 0.287
70

RP11-284N8.3

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-590-5p;hsa-miR-93-5p 10 TGFBR2 Sponge network -0.845 0.52848 -2.733 2.0E-5 0.286
71 RP4-798P15.3 hsa-let-7a-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-30b-5p;hsa-miR-30e-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-3p 10 BMPR2 Sponge network -0.893 0.37877 -1.126 0.00109 0.285
72

MIR497HG

hsa-let-7d-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-33a-3p;hsa-miR-500a-5p 11 THBS1 Sponge network -6.146 0.00024 -3.751 0.0001 0.282
73

MIR143HG

hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-30b-5p;hsa-miR-30e-5p;hsa-miR-32-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-92a-3p;hsa-miR-93-3p;hsa-miR-93-5p 17 BMPR2 Sponge network -6.51 0 -1.126 0.00109 0.282
74

MIR143HG

hsa-miR-107;hsa-miR-142-3p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-197-3p;hsa-miR-19b-3p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-30d-5p;hsa-miR-30e-5p;hsa-miR-590-3p 12 ACVR1 Sponge network -6.51 0 -0.765 0.04389 0.281
75

RP11-344E13.3

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-25-3p;hsa-miR-32-5p;hsa-miR-34a-5p;hsa-miR-363-3p;hsa-miR-590-3p;hsa-miR-93-5p 10 SMAD7 Sponge network -4.307 3.0E-5 -0.959 0.0367 0.279
76

EMX2OS

hsa-let-7d-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-32-5p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-92a-3p 13 THBS1 Sponge network -6.205 0.00015 -3.751 0.0001 0.273
77

ADAMTS9-AS1

hsa-let-7f-1-3p;hsa-miR-142-5p;hsa-miR-155-5p;hsa-miR-2355-5p;hsa-miR-27a-3p;hsa-miR-3682-3p;hsa-miR-452-3p;hsa-miR-590-3p;hsa-miR-625-3p;hsa-miR-629-3p 10 SMAD9 Sponge network -8.573 0.00012 -2.738 0.0193 0.27
78

EMX2OS

hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-142-5p;hsa-miR-155-5p;hsa-miR-2355-5p;hsa-miR-27a-3p;hsa-miR-330-3p;hsa-miR-452-3p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-944 11 SMAD9 Sponge network -6.205 0.00015 -2.738 0.0193 0.268
79

TRHDE-AS1

hsa-let-7d-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-32-5p;hsa-miR-33a-3p;hsa-miR-590-3p;hsa-miR-92a-3p 11 THBS1 Sponge network -6.205 0.01165 -3.751 0.0001 0.266
80

NR2F2-AS1

hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-32-5p;hsa-miR-590-3p;hsa-miR-92a-3p;hsa-miR-93-3p;hsa-miR-93-5p 13 BMPR2 Sponge network -3.785 0.00281 -1.126 0.00109 0.265
81

RP11-166D19.1

hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-142-5p;hsa-miR-155-5p;hsa-miR-27a-3p;hsa-miR-452-3p;hsa-miR-590-3p;hsa-miR-625-3p;hsa-miR-629-3p;hsa-miR-944 10 SMAD9 Sponge network -4.209 2.0E-5 -2.738 0.0193 0.265
82

ADAMTS9-AS1

hsa-let-7d-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-32-5p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-616-5p;hsa-miR-92a-3p 15 THBS1 Sponge network -8.573 0.00012 -3.751 0.0001 0.263
83

TPTEP1

hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-142-5p;hsa-miR-155-5p;hsa-miR-27a-3p;hsa-miR-3682-3p;hsa-miR-452-3p;hsa-miR-590-3p;hsa-miR-625-3p;hsa-miR-629-3p 10 SMAD9 Sponge network -4.398 5.0E-5 -2.738 0.0193 0.263
84

RP11-284N8.3

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-335-3p;hsa-miR-590-5p;hsa-miR-93-5p;hsa-miR-96-5p 10 THBS2 Sponge network -0.845 0.52848 -2.628 0.00636 0.262
85

RP11-567M16.1

hsa-let-7g-3p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-29b-2-5p;hsa-miR-30d-3p;hsa-miR-335-3p;hsa-miR-345-5p;hsa-miR-616-5p;hsa-miR-671-5p;hsa-miR-769-5p 10 SMAD3 Sponge network -2.638 0.21408 0.16 0.77852 0.26
86 CTD-2554C21.2 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-93-5p 10 TGFBR2 Sponge network -6.968 0.00817 -2.733 2.0E-5 0.259
87

RP11-130L8.1

hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p 12 BMPR2 Sponge network -4.329 1.0E-5 -1.126 0.00109 0.259
88

TRHDE-AS1

hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-30b-5p;hsa-miR-32-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-92a-3p;hsa-miR-93-3p;hsa-miR-93-5p 17 BMPR2 Sponge network -6.205 0.01165 -1.126 0.00109 0.257
89

RP11-887P2.5

hsa-let-7d-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-33a-3p;hsa-miR-576-5p 11 THBS1 Sponge network -9.865 1.0E-5 -3.751 0.0001 0.255
90

RP11-389C8.2

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-93-5p 12 TGFBR2 Sponge network -3.089 2.0E-5 -2.733 2.0E-5 0.253
91

RP11-597D13.9

hsa-let-7d-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-33a-3p;hsa-miR-92a-3p 11 THBS1 Sponge network -2.494 0.07597 -3.751 0.0001 0.253
92

LINC00672

hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-33a-3p;hsa-miR-590-3p;hsa-miR-93-5p 12 TGFBR2 Sponge network -2.547 4.0E-5 -2.733 2.0E-5 0.252
93

RP11-597D13.9

hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-590-5p;hsa-miR-93-5p;hsa-miR-96-5p 12 THBS2 Sponge network -2.494 0.07597 -2.628 0.00636 0.252

Quest ID: 91bb660986d03718b6a49b4a818debaf